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Abstract
Role of the Dietitian in Multidisciplinary Treatment of Polycystic Ovary Syndrome
Wendy Thompson
Background: Polycystic Ovary Syndrome (PCOS) is the most common reproductive endocrine
disorder in females. Genetic and lifestyle factors influence the etiology and insulin resistance
plays a key role in the pathogenesis of PCOS.
Objective: To investigate the current trends and future implications of multidisciplinary PCOS
clinics while emphasizing the role and challenges for dietitians.
Methods: The study design was a two-phase formative investigation of PCOS focused
practitioners through an anonymous, internet-based survey (Qualtrics, Provo, UT) followed by
focus groups done via teleconference. Focus group data was analyzed using Braun and Clarke’s
method of thematic analysis.
Participants: Survey respondents included 261 health care providers, 59% physicians, 20%
dietitians, from around the world (64% from the United States); the majority (59%) represented
multidisciplinary facilities. Focus group participants included four dietitians, three physicians, a
health psychologist and a licensed nutritionist that had 7-25 years of experience treating PCOS.
Results: From the survey, the barriers for future multidisciplinary clinics included:
money/resources, insurance reimbursement, and difference of opinions; the potential advantages
included: more comprehensive and integrated care, greater convenience/efficiency, better longterm outcomes, and increased access to disciplines. Dietitians were involved in 71% of the
clinics represented in the survey and 89% of respondents stated that dietitians need to be
‘involved’ or ‘highly involved’ in PCOS treatment. Focus group participants stated the greatest
challenges for dietitians include insurance, lack of PCOS knowledge, and lack of physician
referrals. Overall, nutritional interventions are not very accessible for the majority of PCOS
patients.
Conclusions and Implications: PCOS is a complex condition that requires the expertise of
multiple provider types to treat the syndrome in its entirety. Most providers agreed that
multidisciplinary clinics would ultimately lead to a better prognosis for PCOS patients. A
greater emphasis needs to be placed on educating the medical community, including dietitians
and physicians, on the importance of specialized nutrition counseling and lobbying for insurance
reimbursement. Having access to dietitians educated on PCOS is likely the best way to ensure
that PCOS patients have access to lifestyle interventions, which is considered to be the first-line
treatment for PCOS.
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Chapter I: Introduction
i. Problem
Polycystic ovarian syndrome (PCOS) is thought to be the most common endocrine
disorder found in women. 1,2 PCOS impacts women of all races and ethnicities who are of
reproductive age. In unspecified populations the prevalence of PCOS has a reported incidence
rate of 3-10%. 3,4 PCOS is a syndrome that is seen only in women and is most often
characterized by an imbalance of the sex hormones. 1 Common symptoms include irregular
menstrual cycles, ovarian cysts, and hirsutism. 2 Features of the syndrome may also include
infertility, insulin-resistance, impaired glucose tolerance (Type 2 Diabetes), dyslipidemia, and
cardiovascular disease due to increased risk factors. 1,5 The etiology of PCOS is not completely
understood and there is no known cause, although a genetic component and lifestyle influences
have been identified. 1,2,5 Due to the heterogeneous and multifactorial nature of PCOS symptoms
there is a lack of a clear universal consensus regarding the definition and diagnostic criteria. 1,6
Individuals with PCOS are in need of specialized, individualized, and focused care from a
variety of health care providers who can work as a team to treat PCOS comprehensively. There is a
large gap in the literature with very few studies documenting or assessing multidisciplinary PCOS
treatment facilities. The limited research documenting the efficacy of multidisciplinary PCOS
clinic have demonstrated increased weight loss, high patient satisfaction rates, and high retention
rates. 7,8
The current literature lacks the perspectives of specific health care providers (HCP) on
PCOS and enough supporting evidence on the benefits of dietitians for PCOS treatment. To our
knowledge this is the first study that seeks to gain insight from a mix of HCP who frequently treat
PCOS patients on the potential implications of multidisciplinary clinics and the challenges of
involving dietitians in the care of PCOS.
1

ii. Hypothesis and Objectives
Due to the complexity and heterogeneity of polycystic ovary syndrome, practitioners who
work with patients with PCOS will describe the benefits of specialized, individualized, and
multidisciplinary care. It is hypothesized that dietitians are not being utilization to their maximum
involvement due to a variety of barriers.
In order to test the hypothesis the formative study’s objectives were to:
1. To investigate the current trends in multidisciplinary treatment of PCOS across
different provider types
2. To describe potential implications of future multidisciplinary PCOS clinics
3. To explore the role, importance and challenges for RDs in multidisciplinary PCOS
treatment

iii. Limitations
Our survey sample did not allow for an associative analysis, to explore the potential
association between different providers or type of treatment with various methods or outcomes.
Also, the survey relied on self-reported data with no means of verification of credentials or
experience. Several limitations were imposed on this study that accompany the nature of
convenience sampling and focus groups. This study did seek the opinions of experts and it was not
meant to be generalizable to the entire population of health care providers. It is possible that
different experts would have different opinions in regards to PCOS but after reaching saturation it
is unlikely the results would have been significantly affected. This purposive sample provided
access to rich qualitative data that cannot be gathered though a broad-spread survey.
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Chapter II: Review of the Literature
i. Clinical Presentation of PCOS
PCOS is the most reproductive endocrine disorder in females. 1,2 PCOS has a variety of
phenotypes therefore is presents with a broad spectrum of clinical symptoms and risk factors.
Insulin resistance is thought to play a central role in the etiology of PCOS and is present in 5090% of women with PCOS (depending on diagnostic criteria used), which is significantly worse
than age and BMI-matched control women. 9 It has been estimated that 38 – 88% of women with
PCOS are overweight or obese across the world, with an increased rate in the United States to
mirror the higher obesity rates in the non-PCOS population. 9 Insulin resistance does present in
individuals with lean PCOS as well as overweight and obese women.
Another characteristic feature of PCOS in hyperandrogenism, which refers to elevated
male-hormones (androgens), such as testosterone. Hyperandrogenemia can be diagnosed
clinically through the presence of acne, hirsutism (unwanted hair growth around the face, chest,
or trunk), or alopecia (male-pattern baldness or the thinning of hair). It can also be diagnosed
biochemically through a blood test. In a large study of over 1,000 women with androgen excess,
659 presented with hirsutism and 78.4% of the hirsute women were diagnosed with PCOS under
the 1990 NIH criteria. 10
PCOS is often associated with infertility, which presents in an estimated 40% of women
diagnosed with PCOS. 11 The root of infertility in these women is likely from the menstrual
disturbances, which is often presented as oligomenorrhea (with 85-90% of women with PCOS),
amenorrhea (presents in 30-40% of women with PCOS), or abnormally long or erratic menstrual
patterns. 11 It is also important to mention that up to 30% women diagnosed with PCOS have
normal menstrual cycles, 11 which emphasizes the high degree of heterogeneity in this condition.
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Mental health outcomes are also of a concern when it comes to a multifaceted condition
with dermatological symptoms, weight gain, fertility issues, as well as a variety of risk factors.
Shakerardekani et al. conducted a cross sectional, multi-centric study in Iran on 100 women with
PCOS and found that 45% presented with depression and 30% were considered for possible
cases of other metal disorders. 12 Another study by Coffey et al. in the UK found that PCOS had
a negative impact on health related quality of life, even when compared with a variety of other
health conditions with a relatively small sample size but while using a reliable and valid
evaluation tool. 13
ii. Geographical Prevalence of PCOS
In the current literature there is a large disconnect between the prevalence of PCOS,
geographical regions and race/ethnic factors. There are few studies that have examined specific
subpopulations. These studies are commonly limited by small sample sizes, selection bias, and
are not comparable with other studies’ findings due to inconsistencies with the diagnostic criteria
for PCOS. In order to fully understand the complexity and occurrence of PCOS, the prevalence
needs to be assessed in the subpopulations. It is important for the field to reach the level of
comprehension with PCOS to the extent that diabetes and metabolic syndrome established in
order to improve treatment. 14,15 This review will determine the prevalence of polycystic ovarian
syndrome based on geographical location and race/ethnicity. This will help to determine how
much is understood regarding the risk and diagnosis of PCOS in specific regions of the world.
Understanding the Prevalence of PCOS
In order to begin to understand what is currently known about the prevalence in subgroup
populations of PCOS the complexity and issues of the current diagnostic criteria must be
understood. There are three different sets of diagnostic criteria that used in the field which have

4

been set by National Institutes of Health’s (NIH) international conference on PCOS in 1990, the
European Society of Human Reproduction and Embryology and the American Society for
Reproductive Medicine (ESHRE/ASRM) in 2003 (referred to as the Rotterdam criteria), and the
Androgen Excess Society & PCOS Society (AE-PCOS) in 2006. 5,16-18 Each set of criteria has
slightly different clinical, biological, and image-based findings to determine the presence or
absence of PCOS. 1 The 1990 NIH Criteria suggest that a patient has PCOS if she displays
symptoms of oligoovulation and androgen excess (clinical or biochemical). 5 The Rotterdam
2003 Criteria was developed in response to a need for broader diagnostic criteria. 1 In order to be
diagnosed with PCOS under the Rotterdam criteria (ROT) the individual must exhibit symptoms
in two out of the three categories, which include oligo/anovulation, hyperandrogenism, and the
presence of polycystic ovaries. 5 The most recent criteria that was published by the AE-PCOS in
2006 tightened the criteria to include all three symptoms used in the Rotterdam criteria in an
effort to give an evidence-based definition to PCOS. 5,16 All three diagnostic criteria sets have
specific exclusion criteria that differ. The diagnostic criteria is constantly evolving and is
considered to be one of the most debated topics in the field of endocrinology 16 making the
prevalence of PCOS difficult to determine with consistency. It has been previously stated that
because PCOS is a clinical syndrome, and there is no criteria that is fully sufficient for
diagnosis.19
Table 1: Diagnostic Criteria for PCOS
NIH 1990
• Hyperandrogenism
• Chronic Anovulation

Rotterdam 2003

AE-PCOS Society 2006
• Hyperandrogenism
• Ovarian dysfunction

---Both criteria needed

• Hyperandrogenism
• Oligo-and/or anovulation
• Polycystic ovaries
---2 of 3 criteria needed

First developed and most
commonly used criteria today

Formulated to expand on NIH
diagnostic definition

Formulated to provide an evidencebased definition

---Both criteria needed

5

Effect of the Diagnostic Criteria on Prevalence
Changes in the diagnostic criteria greatly affect the prevalence of PCOS. Prevalence rates
have been reported as low as 1.6% using a combination of all three criteria 1 and as high as 18%
2

in similar Caucasian populations using the Rotterdam criteria. 20,21 A statistical report by

Futterweit, estimated that 50 – 75% of women with PCOS are unaware that they even have this
syndrome. 22 A retrospective cohort study by Amato et al. 16 assessed a group of 204 agematched women who were suspected to have PCOS to determine the difference in prevalence
based on the diagnostic criteria. This study found that the prevalence of PCOS in the identified
population to be 51% according to NIH, 83% with ROT, 70.6% with AE-PCOS, and only 49%
to fit the PCOS diagnosis under all three categorical descriptions. 16 These findings all showed a
difference in the prevalence as well as the frequency and severity of symptoms. In a cohort
study6 using a large anovulation-screening database all cases were assessed under the Rotterdam
criteria and then redefined and diagnosed under the NIH criteria to determine the prevalence of
PCOS according to the two different definitions. When the subjects were diagnosed according to
the Rotterdam criteria there was a 1.5 times larger group that was diagnosed than when the same
subjects were diagnosed using the NIH criteria. Under the Rotterdam criteria there was a greater
frequency of obesity, insulin sensitivity, and the diagnosis of PCOS itself. 6 This study used
appropriate groups and used the same subjects to assess an accurate depiction of the differences
that can occur between the criteria. Another study 2 found that the Rotterdam and AES
prevalence estimates were nearly twice that of the NIH criteria when classified on the same
participants. The lack of consistency and clarity between the diagnosis criteria affects the
comparability and the standardization of all clinical treatments and research findings dealing
with PCOS.
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There is a limited amount of literature on previous research regarding the prevalence of
PCOS dependent on a geographical location, specific race or ethnicity, or how the prevalence of
PCOS is related to the occurrence of additional health disparities. Previous studies are commonly
limited by a small sample size, fewer than 400, conducted at only one facility, and are not fully
comparable due to the lack of consistency in the use of diagnostic criteria. 1 It has been stated
that there is a significant difference seen in the symptoms presented across geographical
locations and between differing race/ethnic groups. 23
Prevalence of PCOS Across the US
To our knowledge, Okoroh et al. 1 is the only study to assess and compare regional
prevalence of PCOS and its various phenotypes across the United States (US) and the first to use
all available criteria to estimate the prevalence in the US. This is also believed to be the one of
the largest prevalence studies done on a geographically diverse population within the United
States. This research showed a higher prevalence of PCOS concentrated in the southern US than
anywhere else in the US. This study showed that following the South, in order of decreasing
prevalence, was the North Central, West, and then the North East with the lowest prevalence. 1
This was a large scale study that analyzed a commercial database containing claim reports that
were collected from 2003-2008 looking at over 12 million privately insured women aged 18-45
from geographically diverse states. Only 1.6% of women met at least one diagnostic criteria for
PCOS. 1 This prevalence may be a low estimate since this a retrospective study only had access
to medical charts previously completed and did not see the patients directly for an extensive
clinical exam. There is also the possibility of the information on the charts being improperly
coded leading to missed diagnosis. Since it is not uncommon for PCOS to go undiagnosed, it is
extremely plausible that this article underestimates the prevalence of PCOS significantly.
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Prevalence of PCOS in Caucasians Across the World
Various studies have assessed Caucasians in the US, Spain, Australia, and Greece to
determine whether or not Caucasian populations in other countries showed similar prevalence
rates across the world.
A previous study, by Asuncion et al., 24 prospectively estimated the prevalence of PCOS
using a design similar to Knochenhauer et al. 3 that selected women in an unbiased manner by
using data from 154 consecutive Caucasian blood donors at a hospital in Madrid, Spain. Using
the NIH diagnostic criteria, the study found an incidence rate for PCOS of 6.5%. 24 One
limitation of this study was that is was a small study and although the selection was not biased, it
was not completely randomized and is unlikely to be representative of the population in that area.
A large retrospective birth cohort was designed by March et al. 2 to create a
representative estimate of the prevalence of PCOS in those born in Adelaide, Australia. 728
female reproductive age subjects were assessed that were all born at a single maternity hospital
and could be located, interviewed, and clinically examined. This study took into consideration
the lack of consistency between the diagnostic criteria and assessed the patients according to
each criteria to determine prevalence rates specific to the criteria. The study determined a
prevalence of 8.7±2.0%, 11.9±2.4%, 10.2±2.2% according to NIH, Rotterdam, and the AES
criteria respectively. These numbers increased to 17.8±2.8% under the Rotterdam criteria and
12.0±2.4% according the AES criteria when imputed data was included for those women who
did not have an ultrasound. 2 The main strengths of this study were that is the largest and only
community-based study that looked at the prevalence of PCOS in a nearly homogeneous
Caucasian population. Although these incidence rates seem higher than those determined in the
United States this population was primarily Caucasian and is said to be comparable to the US, 25
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in terms of obesity rates and waist circumference, the rates of Australians were still lower than in
the Americans. 26-28 While the previous study looked primarily at Caucasian Australian women,
which made up 94% of their participants, other studies have looked at Australian indigenous
women and found very different results that are discussed below. 29
Prevalence of PCOS Across Different Races/Ethnicities
Studies have suggested that the prevalence of PCOS may vary between different races
and ethnicities. The following studies assessed the prevalence of PCOS looking at specific
race/ethnicities in a single geographical area.
Due the wide-variety of ethnic groups of Asians it is expected that the variance or
symptoms between individuals’ different ethnicities will vary and this has been documented
across multiple studies. A community-based, cross-sectional study assessed a random sample
that was representative of the community of over 3,000 women between the ages of 15 and 39 in
Sri Lanka. The study by Kumarapeli, et al., 30 found a prevalence rate of 6.3% (95% CI: 5.96.8%) based on the Rotterdam criteria. This study used a survey to first narrow down the
probable cases and controls and then performed a clinical examination to further deduce
probable cases and then used ultrasound tests to confirm the identified PCOS cases. Over 90
percent of women self-reported symptoms of oligo/amenorrhea and/or hirsutism were confirmed
to have PCOS according to Rotterdam criteria. 30 This method showed that a simple
questionnaire-based survey may be an effective and simple tool that could be used for PCOS
screening in South Asia and even other areas of the world. In this study only 0.65% of those with
PCOS had been previously diagnosed. It is suspected that there would be an increased
prevalence of PCOS in Sri Lankan women when compared with Caucasians due to the known
link between type 2 Diabetes Mellitus and the high prevalence of diabetes in Sri Lanka. 30,31 Due
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to differing diagnostic criteria used in similar studies in the US it is difficult to compare the
results directly to determine the similarity. These findings were consistent with those
documented in Southern Europe. 30 It has been reported that the prevalence of PCOS is
considered to be higher in South Asians than in Caucasians residing in the United Kingdom. 32
Fifty-two percent of all Asian women who reside in the Indian subcontinent have been found to
present with polycystic ovaries, which is considered to the highest reported prevalence. 33 The
estimated prevalence of women with polycystic ovaries in the US is approximately 21% of a
select population. 34 Although Japan has lower rates of obesity and hirsutism, the Japanese still
have comparable rates of androgen excess and insulin resistance to the US and Italy. 23 No
known studies have been published describing the prevalence of PCOS in Japan or Italy in order
to compare the populations further.
According to Moran, 35 a prevalence of 6.0% (95% CI: 1.9-10.1%), as diagnosed by the
NIH criteria, or 6.6% (95% CI: 2.3-10.9%) under the Rotterdam criteria was found in a
homogenous group of Mexican women residing in Mexico City. This study could have been
limited by a small sample size of 150 women who all joined the study voluntarily. Strengths of
this study include the use of two diagnostic criteria sets and the fact that they were all assessed
clinically, biochemically and by a pelvic ultrasound. 35
According to Goodarzi et al., 36 a significantly higher PCOS prevalence has been
documented in Mexican-American women living in Los Angeles that is approaching 13%. 4,35,36
This study prevalence could be impacted by a confounding factor from bias stemming from their
selection of individuals who all had a family history of coronary artery disease. There was no
clinical evaluation with the subjects because this study relied solely on self-reported data via a
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questionnaire, which could significantly skew their results. Unlike most studies this study failed
to remove patients with hyperandrogenism connected with a related disorder.
The differences between these studies focused on Mexican women could imply that there
is a difference in lifestyle from those residing in Mexico vs. United States. If the experimental
designs were similar in methodology and better controlled then this assumption could be stated
with more confidence. It is plausible that there is a higher prevalence of PCOS in MexicanAmericans because in a study comparing Caucasian women and Mexican-American women with
PCOS found that they have been found to have a higher age-specific prevalence of insulin
resistance and a higher body mass index (BMI) when compared to non-Hispanic Whites. The
study used a smaller sample size of 83 participants but consistently observed significantly higher
mean values for BMI, fasting insulin, and homeostasis model assessment (HOMA) in MexicanAmerican women compared to the Caucasian women. 4 One of the most prominent features of
PCOS is insulin resistance, which is found in 50-70% of individuals with PCOS. 36
Despite the correlation between a higher prevalence of PCOS and a higher Black
population in the Southern US, Knonchenhauer et al., 3 found that there are no significant racial
differences between Whites and Blacks living in Alabama with a prevalence of 4.7% and 3.4%,
respectively. 3 This study had a sample size of 369 women in the Southeastern United States that
were between the ages of 18-45 who were examined as part of a pre-employment physical. The
subjects were assessed for PCOS according to the NIH guidelines. This study was detailed and
avoided bias in the selection of their participants although, due to the chosen diagnostic criteria it
did not include the polycystic ovarian morphology or ultrasound as part of the examination.
Other studies by Azziz et al., 20 have examined this hypothesis using the same database
and the same criteria. These studies confirmed the finding of no significant difference, showing a
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prevalence of 8.0% for Black women and 4.8% for White women in Alabama, potentially due to
a small sample size (n=400). 20
Davis et al. reported results that are suggestive of a preliminary indication that
indigenous Australian women could have a prevalence as high as 26%. It is important to note
that this study is limited by its small sample size (N=38) and a PCOS diagnosis based off of the
presence of oligomenorrhea and hirsutism and/or hyperandrogenemia. The measures collected
from the participants included hirsutism (from facial scoring only), BMI and waist
circumference, insulin and glucose levels, and hormone analysis to test total testosterone and sex
hormone binding globulin (SHBG), which were used to calculate a free androgen index. 29 It was
expected that the prevalence found in the indigenous people would vary from the rest of the
population due to their rapid change from a hunter-gatherer way of life to a sedentary life-style
with a high-fat and nutritionally poor diet. This population has especially high rates of hirsutism,
central obesity, and type 2 diabetes compared to Caucasians. 29 These symptoms are symptoms
of PCOS and the increased prevalence may be attributed to PCOS or increase their risk for
developing PCOS.
A cross-sectional study that assessed 192 women between the ages of 17 and 45 who
were living on the Greek island of Lesbos determined the prevalence of PCOS, according to the
NIH criteria to be 6.77%. 37 This study recruited participants via a convenience sample by
accepting those who responded to their offer of a free medical examination by an
endocrinologist. This method introduced bias and may have altered the results by attracting more
individuals who think they need to see a doctor than those who consider themselves healthy.
Regardless of the potential bias, this value parallels the typical prevalence rate in the United
States. 3
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PCOS Prevalence Conclusion
Based on the NIH diagnostic criteria, there is a similar prevalence of PCOS between 69% documented across the United States, the United Kingdom, Spain, Greece, Australia, and
Mexico. 38 This information suggests that there are no racial or ethnic influences on the
prevalence of PCOS. Due to the lack of comparability amongst the studies, biased group
selections, and small sample sizes it is recommended that further research be conducted before
this generalized statement is accepted. There are multiple hypothesized reasons for the lack of
understanding of the risk and diagnosis of PCOS and one main reason could be the conflicting
diagnostic criteria. The different components of the diagnostic criteria cause alterations in the
prevalence across the NIH 1990 Criteria, Rotterdam 2003 Criteria, and AE-PCOS 2006 Criteria.
5

National prevalence rates have been reported as low as 1.6% using a combination of all three

criteria 1 and as high as 6.6% using 1990 NIH criteria in similar American populations. 20 One
strength that was noted between all studies was that they all observed a similar age group to
depict women of reproductive age. In particular, most of the studies looked at the age group
between 18-45. 1,3,20,24,37 There is limited literature that exists but there has been similar
prevalence rates between Whites of European decent, African-American, and Mexican women
noted. 38 Due to the inconsistency between diagnostic criteria and recruiting methods it is
unlikely that all studies in this review are comparable enough to infer conclusive differences
upon. The existing data is not conclusive enough to determine whether or not there is any
significant differences in the prevalence of PCOS across geographical location, racial or ethnic
groups.
Future research is needed to determine a better diagnostic criteria and ways to improve
diagnosis so that less individuals with PCOS are undiagnosed. These will be the first steps to
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determining a more accurate prevalence, which can then be assessed according to subpopulations to achieve a better understanding of this multifaceted syndrome. This topic is in need
of large-scale, random, populational studies across the world that look at the prevalence of PCOS
according to the all of the established diagnostic criteria is specific sub-populations that can be
repeated with many different sub-groups.
iii. The Current Description and Future Need for Polycystic Ovary Syndrome Clinics
Polycystic ovarian syndrome (PCOS) is thought to be the most common endocrine
disorder found in women. 1,2 PCOS impacts women of all races and ethnicities who are of
childbearing age. PCOS is associated with a significant increase in risk factors such as
cardiovascular disease, type 2 diabetes, and infertility. 5 The etiology of PCOS is not completely
understood, although a genetic component has been identified. 5 Given the heterogeneity of its
symptoms and constantly evolving (and debated) diagnostic criteria, the prevalence PCOS can be
difficult to pinpoint. The prevalence of PCOS is commonly thought to vary between 5-10%
depending on diagnostic criteria and sample population. 1,2,5 It has been previously stated that
because PCOS is a clinical syndrome, and there is no criteria that is fully sufficient for diagnosis
19

The main goal of this review is to determine the need for multidisciplinary PCOS clinics

based on their contribution to treatment outcomes and assess the current literature on existing
multidisciplinary PCOS clinics.
Significance of the Problem
PCOS is a multifaceted and complex syndrome that requires care from multiple providers
to fully treat the full spectrum of PCOS. It can be difficult to treat due to its heterogeneity
between patients, which therefore requires specialized, individualized and focused care. PCOS is
most often diagnosed in adolescents struggling with menstrual issues or women with infertility;
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combine those issues with hirsutism, high insulin levels, weight-gain, and acne 1 and this leads to
a vulnerable and frustrated population. There are many aspects involved in evaluating and
treating PCOS patients, including: regulating the menstrual cycle, addressing metabolic
abnormalities, normalizing nutrition (i.e. weight loss if overweight), psychological treatment for
poor self-image, depression, and anxiety, and addressing concerns such as infertility and
increased risk of comorbidities. 7,39 A multidisciplinary treatment approach to PCOS is thought
to be an effective strategy that will enable the coordination of care and also serve as an
innovative platform for research on the full spectrum of PCOS. 8
Another reason to support the need for multidisciplinary PCOS clinics is the high rate of
PCOS patients who remain undiagnosed when only seeing one specialist. In a study by BroderFingert et al. 40 data was collected on an inner-city clinic by a retrospective chart review in a
hospital based pediatric clinic in New York City. Data was analyzed from 60 female patients
between the age of 13 and 19 with a primary ICD-9 diagnosis of ovarian dysfunction, menstrual
irregularity, or hirsutism who were selected randomly. The primary outcome of this study looked
at the rates of assessment for the diagnostic criteria of PCOS and selected co-morbidities. Only
25% of the patients in the study with suspected PCOS (according to any of the three common
diagnostic criterias) were evaluated for PCOS. 40 Only 2 patients (3.33%) were evaluated for
common co-morbidities associated with PCOS. 40 A full evaluation for PCOS at this clinic
included: menstrual irregularities, hirsutism, ovarian ultrasound, fasting glucose, fasting insulin,
lipid profile (HDL, LDL and triglycerides), testosterone, and FSH to LH ratio. Twenty-eight out
of 60 patients presented with menstrual irregularity in addition to one of the following signs:
obesity, hirsutism, and/or acne. 40 Of those 28 patients only 15 (54%) were evaluated for PCOS,
according to the Rotterdam Criteria, and only 7% were evaluated for co-morbidities. 40 As
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demonstrated by the lack of PCOS evaluation in patients with one or more symptoms
demonstrates that PCOS is under-evaluated and under-diagnosed in this pediatric population and
most likely throughout the US. This study’s strengths included their exhaustive evaluation
measures to diagnosis PCOS and the fact that this the first study to assess the rate of undiagnosed
PCOS cases in an inner-city population. Due to the reliance on a retrospective chart review there
is a possibility of inadequate or incomplete medical chart reporting, which could alter the rate of
existing diagnosis.
Sivayoganathan et al. showed that the percent of patients that go undiagnosed with PCOS
might vary greatly depending on the type of clinic. The data for this study was collected on 70
women using a prospective cross-sectional observational study at four different clinics at Leeds
General Infirmary in the United Kingdom. Participants were all assessed for PCOS by a full
endocrine and metabolic profile as well as an ultrasound. In this study, 65% attending the
dermatology clinic, 38% attending the endocrinology clinic, 25% attending the gynecology
clinic, and 15% attending the fertility clinic were confirmed by this study to have PCOS without
a pre-existing evaluation. 41 The difference between the rates of existing diagnosis was shown to
be significant (p=0.0088). 41 Even though all participants experienced menstrual problems there
was a significant difference (p<0.0234) with menstrual patterns and the frequency distribution of
related symptoms between types of clinics. 41 This study also found that four out of six
participants who were found to have diabetes were diagnosed through this study, indicating
possible missed diagnosis of a medically important disorder. 41 Most women were receiving an
oral-glucose test for the first time. This was the first study to compare four different clinics that
often treat the symptoms of PCOS, and it also used an exhaustive evaluation for PCOS. This
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study may have been limited by a relatively small number of participants but significant results
were still found.
Efficacy of Multidisciplinary PCOS Clinics
Very few studies have been done to assess multidisciplinary treatment for PCOS. It is
important to understand the clinical variability that is seen between treatment providers, success
in existing clinics, and additional research promoting the use of a multidisciplinary treatment
team. A cross-sectional study to assess practice heterogeneity by Bonny et al. conducted an
anonymous Internet survey that yielded 127 responses from North American Society of Pediatric
Adolescent Gynecology (NASPAG) members. When the respondents were asked to select their
expertise (more than one could be selected) 64% selected gynecology, 43% selected adolescent
medicine, 13% selected reproductive endocrinology, 6% selected general pediatrics, and 4%
selected endocrinology. 42 The most common first-line treatment therapies included the
prescription of oral contraceptives followed by diet modification and exercise with 98% and 90%
of respondents, respectively. 42 While 65% of clinicians would not make a diagnosis for PCOS
within the first 2 years after menarche, 35% of respondents would. 42 Only 60% of respondents
noted that they look at blood glucose levels at an initial PCOS evaluation. 42 Thyroid stimulating
hormone (TSH) was the most common test completed at an initial PCOS evaluation with just
below 90%. 42 There was a high degree of variability in the hormonal and metabolic evaluations.
The high degree of variability in evaluation is evidenced by the fact that there was not one test
used to diagnose PCOS that was ordered by all clinicians. Even though this survey targeted the
experts in the field who have an interest in PCOS, there was a considerable amount of
heterogeneity within the first diagnostic testing that was normally completed. This study was
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limited due to it being a pilot study that was designed to assess descriptive statistics only, but it
was the first study to address the input across a variety of providers on the evaluation of PCOS.
Currently, there are only two multidisciplinary PCOS treatment facilities that have
published research regarding the outcomes of their clinics. The first multidisciplinary clinic to
examine the benefits of such treatment is the one of the most well-known multidisciplinary
PCOS clinics in the United States, which is at the American Family Children’s Hospital in
Madison, Wisconsin. This clinic has been in existence since 2005. This clinic’s team consists of
two pediatric endocrinologists, a reproductive endocrinologist, an endocrine nurse, a health
psychologist, a dietitian, and a pediatric gynecologist. 7,39 The following two studies were based
off of data collected during the first 33 months of operation (March 2005 – December 2008) of
this clinic. The goal of this study was to characterize patients referred to the adolescent PCOS
clinic by conducting a chart review of all patients (n=70) seen in the first 33 months. Bekx et al.
collected data on initial presentation, age, body mass index (BMI), menstrual pattern, features of
androgen excess, insulin resistance, and dyslipidemia. The average age of the patients at the time
of referral was 16.2 years old but ranged from 11 to 22 years old. 39 Eighty-four percent of
patients had a BMI above the 85th percentile and 70% had a BMI greater than the 95th percentile.
39

They saw a great amount of variance in menstrual patterns and that ranged from primary

amenorrhea to regular cycles. Over 50% of patients showed signs of hirsutism. 39 Only three
cases of type 2 diabetes were confirmed, with two being pre-diagnosed and one diagnosis given
through an oral glucose tolerance test (OGTT). 39 More than 50% of patients were thought to
have insulin resistance that was demonstrated by elevated fasting insulin levels or a fasting
glucose-to-insulin ratio of less than 4.5. 39 Twenty-four percent of patients had elevated fasting
triglyceride levels above 150mg/dL, and 54% had low HDL levels below 50 mg/dL. 39 Due to
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the retrospective design of the chart review for data collection, limitations may result from
coding discrepancies. Also, because the patients were all at different stages of evaluation and
treatment it could cause a variance or skew in data collected. This study did not use confirmatory
testing to ensure the findings of various diagnostic measure due to the lack of financial
justification. Missing data was a slight limitation because not all labs that were ordered were
actually collected, although this is consistent with realistic expectations in clinical settings.
Geier et al. focused on assessing the providers seen by the patients, weight loss and
retention rate at the same clinic. The data for this study was collected by a retrospective chart
review that evaluated 140 adolescent females who had been seen at the PCOS Clinic between
March of 2005 and December of 2008. The average age of patients at their initial visit to the
clinic is 15.9. 7 The procedure of this PCOS clinic is to have all patients see each of the five
providers at the initial visit. Only 41% saw all five providers during the initial visit. All patients
at this clinic saw a pediatric endocrinologist and the endocrine nurse at their first visit and an
additional, 60.9% see a health psychologist, 75.5% see a dietitian, and 70.9% see a gynecologist.
7

Geier et al. found that nearly 70% of patients succeeded in short-term weight stabilization and

57% established weight loss. 7 These patients had an average initial BMI of 34.7 (kg/m2) and
76% had an initial BMI greater than the 95th percentile. 7 This study also found that 71% of
patients returned for a follow-up visit with an average time of 4.5 months between visits. 7 This
high of a retention rate signifies that patients are generally satisfied with the treatment they are
receiving. These high rates of success may be at least partially attributed to self-selection to seek
weight-loss treatment indicating a pre-existing motivation to lose weight. These results might not
be as pronounced in a PCOS population who have not yet reached that stage of change or in an
adult population.
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The second clinic that has assessed the outcomes of multidisciplinary PCOS treatment is
the Royal Berkshire Hospital in Reading, Berkshire, United Kingdom. The first study by Ghosh
et al. was a two-year audit that was conducted on patients attending the multidisciplinary PCOS
clinic from its opening in 2002 until 2004. They analyzed baseline characteristics, adequacy of
investigations, efficacy of treatment, and patient satisfaction. The main complaints of the 127
women who attended this clinic were weight gain, hirsutisim and oligomenorrhoea. 8 These
women had a median age of 30 years and a median BMI of 32 (kg/m2). 8 The majority (55%) of
their patients were offered Metformin (to suppress glucose production in the liver) for treatment
but 12 (17%) discontinued use because of undesirable side effects. 8 Patients using Metformin
compared to those who were not did see a significantly greater amount of weight loss (p<0.0001)
with a median loss of 8kg. 8 Fifty percent of Metformin users with hirsutism saw an
improvement in Ferriman Gallwey (F-G) score but it was less effective in those with very high
initial F-G scores. 8 Metformin also significantly improved menstrual cyclicity from a median of
20 weeks to five weeks (p<0.001). 8 Eight of the 17 women taking Metformin and attempting to
get pregnant had successful pregnancies in the two year time audit. 8 Greater improvements to
hirsutism levels were seen with the 23 women using Spironolactone (a diuretic that also reduces
androgen levels). The median F-G score fell from 19 to 11 over an eight-month time frame. 8 It
is thought that there could be a higher patient satisfaction related to multidisciplinary clinics than
with individual health care professionals. A study conducted at the Royal Berkshire Hospital in
the UK showed that 42 out of 43 patients who completed a patient satisfaction survey reported
that a multidisciplinary, dedicated PCOS clinic was “useful and that they were very happy with
the results.” 43 The patient satisfaction survey should be administered to a greater amount of
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patients to more adequately represent that clinic population as well as be more specific with the
questions and response options for a better picture.
In 2007, Eldridge et al. 44 conducted an audit on a nurse led PCOS weight management
clinic at the Royal Berkshire Hospital in the United Kingdom. -his clinic had participants
meeting once a month for individual appointments. The clinic focused on physical activity
levels, use of food diaries, medications, changes in menstruation, and weight loss data. They
found that there were 61 women who had attended clinic for at least two months. They had a
mean starting BMI of 37.8. Out of the 37 women who attended for at least three months, 32 had
lost weight with a mean loss of 2.88kg. Five of those 32 women lost 5% of their total body
weight, two lost 7.5%, and three participants lost 10%. The average weight loss increased to
4.94kg when women had attended for at least six months. Of the women who lost at least 5% of
their body weight, 71% had kept a food diary, 86% had increased their exercise levels, 86% took
Metformin, and 7% took Orlistat. 44 Since participation was voluntary, these individuals were
motivated enough to enroll and attend, which could increase their results.
The Androgen Excess PCOS Society (AE-PCOS) supports the emphasis of weight loss as
part of lifestyle intervention for the primary treatment option for overweight and obese women
with PCOS due to the strong association between obesity, abdominal obesity, insulin resistance
and features of PCOS. 45 Studies have shown than even a modest amount of weight loss,
accounting to 5% of ones body weight, can reduce the severity of the symptoms for PCOS. 45 A
review by Moran et al., was conducted to determine the most effective way for women to lose
weight. It was determined that achieving weight loss or even maintaining ones weight by
preventing weight gain is best done with assistance from a multidisciplinary team. 46 This
multidisciplinary team should focus on lifestyle management that includes dietary, exercise, and
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behavioral therapy. 46 Behavioral therapy should focus on psychosocial stress while openly
discussing the practical and physiological barriers associated with weight management or weight
loss.
Another review article by Moran et al. sought to compare the effect of different diet
compositions on a variety of outcomes related to PCOS using the findings of six articles. There
were only slight differences between the diets that have been tested with PCOS patients. They
saw a slightly greater weight loss with a monounsaturated fat-enriched diet; improved menstrual
regularity for a low-glycemic index diet; increased free androgen index diet; improved quality of
life for a low-glycemic index diet; and improved depression and self-esteem for a high-protein
diet. 47 The findings of this compilation of research were inconclusive to support significant
differences between any of the diet examined. The findings were conclusive to say that any diet
aimed at reducing weight could lead to clinical benefits to those with PCOS. This indicates that
the weight loss is more important than dietary composition when it comes to PCOS symptom
management.
Multidisciplinary PCOS Clinic Conclusions
There is limited evidence directly related to multidisciplinary PCOS clinics and the
efficacy of their treatment. It is well accepted that PCOS is multifaceted and has a high degree of
heterogeneity among individuals with the syndrome. When treating a patient with PCOS it is
important to focus on treating the patient’s initial needs while decreasing the risk of long-term
risk factors. Symptoms may be better treated if the patient is treated by a variety of specialists all
working together. When individuals are exposed to multiple providers it is less likely that a
PCOS diagnosis will be missed. It makes sense that the sooner PCOS is identified and treatment
is initiated the quality of life of the patient and expression of the syndrome will improve. The
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perceived benefits of multidisciplinary clinics globally include improved patient satisfaction,
greater weight loss, improved body image, and better management of PCOS from a holistic
standpoint.
Further research is needed to assess additional existing multidisciplinary clinics to
determine patient satisfaction and treatment prognosis compared to those seeking treatment from
only one provider. More research is also warranted to gain a better understanding on evidence
based guidelines for treatment of PCOS, especially when it comes to dietary recommendation.

iv. Lifestyle Interventions and the Role of Registered Dietitians in the Treatment of PCOS
Lifestyle Interventions in the Treatment of PCOS
It is important to realize that PCOS is a chronic disease with no known cure. PCOS
typically requires a broad spectrum of treatment including pharmacology and lifestyle
interventions to best manage the symptoms and disease risk associated with PCOS. Lifestyle
interventions include the combination of dietary changes, increased physical activity, stress
management and cessation of smoking. A general consensus in the current literature supports
the use of lifestyle intervention as the first-line treatment for patients with PCOS, especially
those who are overweight and obese. 48 Looking beyond that broad statement, there is very
limited evidence for specific dietary guidelines for the treatment of PCOS. The benefits of
weight loss are prevalent in the literature but there is not enough data to support one optimal
PCOS diet.
Insulin resistance is found in 50-70% of women with PCOS, regardless of weight,
therefore improving insulin resistance is a large focus of dietary and lifestyle interventions. 49,50
Even modest weight loss, of 5% of body weight, in overweight women with PCOS has been
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shown to improve a variety of reproductive, metabolic, and psychological features. 48 Although
the majority of research focuses on weight loss and the importance of dietary and lifestyle
intervention in overweight women with PCOS, there are a small number of findings that support
the importance of lifestyle management, including diet and exercise, that extend beyond weight
loss to improve hypertension, insulin resistance, and elevated blood glucose levels. 51-53
Various studies have looked at a variety of macronutrient ratios, low carbohydrate, high
protein, altering fatty acid intake, and a low glycemic index (GI) or glycemic load but there is
inadequate evidence to support the findings of an optimal diet for women with PCOS. 54 Despite
the fact that this review found no conclusive evidence for an optimal diet, it was shown that
weight loss improved the presentation of PCOS in almost all of the studies regardless of dietary
composition. 54 This evidence supports the statement that weight loss should be targeted in all
overweight or obese women with a diagnosis of PCOS through caloric restriction accompanied
by adequate nutritional intake and healthy food selections regardless of the specific diet
composition.
Currently there are no known published dietary guidelines or consensus statements in the
United States for the dietary management of women with PCOS that have been put forth by a
reputable organization.
The Role of Registered Dietitians in the Treatment of PCOS
Very few studies have explored the role of dietitians in the treatment of PCOS or the
added benefit they could potentially provide. One study investigated the general attitudes
towards diet and exercise, the extent of the implementation of lifestyle interventions that these
women were provided, and the general knowledge that women with PCOS have about their
condition. 55 This study took place in the United Kingdom (UK) and interviewed 53 pre-
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menopausal women with a confirmed diagnosis of PCOS. This study found that all subjects
identified the importance for weight management for PCOS yet only nine out of 35 (26%)
overweight women had ever received a referral to a dietitian. The majority of these women
reported receiving most of information from the Internet and their endocrinologist who they
typically see twice a year. Even though lifestyle intervention is recommended as the first-line
treatment for PCOS, only 31% of overweight subjects reported being on a weight-reducing diet
(with only 23% have success on their current diet) and 63% reported exercising regularly. This
study found that 80% of overweight subjects reported weight loss to be difficult and only 26%
had been referred to a dietitian so they were receiving very minimal assistance. 55 It is suggested
that by providing these patients with access to specialized dietitians and more frequent
appointments the success rate for weight loss and clinical outcomes would be increased greatly.
A study by Geier et al. 7 , that was discussed previously, has shown that the patients who
saw the most success with weight loss had met with a dietitian and a health psychologist. This
study, which provided multidisciplinary treatment, saw successful weight loss in 57% of patients
who returned for a follow-up visit (1.5-12 months after initial visit with a mean interval of 4.5
months) and 70% of patients had weight stabilization. These differences can likely be attributed
to the incorporation of dietitians and health psychologist to provide the proper nutrition and
motivational counseling.
One study assessed the specific diet and lifestyle advice that was provided by 105
dietitians in the UK who worked frequently with PCOS patients. 56 This study found that about
one-third of dietitians that worked with PCOS worked together with other healthcare
professionals in a multidisciplinary team approach. All dietitians reported recommending
physical activity. The most common dietary approach recommended by these dietitians was to
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reduce energy intake (78%) or select lower glycemic index foods (77%), often times in
conjunction with each other. Another approach was the alteration in macronutrients with the
most common change, reported by 49% of responders, was lowering fat intake, followed by
reducing carbohydrates (16%), and only 3% advocating an increase in protein. Other general
dietary advice commonly consisted of increasing fiber and reducing saturated fat intake. It was
reported that overweight and obese patients were seen more frequently by dietitians, with only
24% of RD reported seeing patients with lean PCOS regularly. When asked about the different
advice given to lean women with PCOS, dietitians reported primarily focusing on reducing the
GI (n=24), healthy eating (n=9), and increasing physical activity (n=6). It is important to point
out that only 10% of dietitians reported having any departmental policy for the dietary
management of PCOS. When looking at the level of confidence that these dietitians have in
treating PCOS they found that only 34% of responders reported feeling well informed of the
literature. This article supports the need for evidence-based guidelines for the dietary
management of PCOS because 64% believed the available information is insufficient.
The second aspect of this study looked at the dietary habits of 203 women through a
survey and a food diary and looked at where they got their information. 56 This study found that
only 15% of the 203 women with PCOS who completed the survey had ever seen a dietitian and
that number reduced to 3% that had seen a dietitian during more than two appointments. When
assessing where these patients got their nutritional information 22% reported using books and
21% received nutritional advice from their physician. This study also pointed out differences in
referral and utilization of dietary resources for overweight/obese PCOS patients compared with
lean women with PCOS. Overweight/obese patients were more likely to receive dietary advice
from a dietitian (21%) and a doctor (25%) than lean women (10% and 17%, respectively). These

26

women with PCOS were then asked to rate the effect of diet or lifestyle modification and 74%
stated an improvement in PCOS symptoms and 19% reported an improvement in weight loss.
The highest reported perception of greatest improvement in symptoms, which was mentioned by
84% of the women who were increasing their physician activity (which, was 48% of
respondents). Of the 32% of women with PCOS following a low GI index diet, 67% stated that
they felt it improved their symptoms. Of the 30% who reported taking dietary/herbal
supplement, 56% reported a beneficial effect. This evidence supports the conclusion that PCOS
is an important condition and dietitians should be aware of the condition and push to increase
awareness.
A dietitian and exercise physiologist, Monika Woolsey, MS, RD, believes that there are a
variety of challenges for women with PCOS in regards to working with health professionals in
regards to diagnosing and treating PCOS. 57 According to Woolsey, physicians tend to dismiss
patients and not see endocrine disorders as a valid explanation for weight issues. When PCOS is
not treated properly, and diet is not addressed, then symptoms can worsen. In Woolsey’s
opinion, she has seen dietitians face challenges gaining the trust from patients, because they are
afraid of being judged or because previous advice did not help. Woolsey feels that dietitians are
often times intimidated by endocrinology because it is complex, but in order to fully assist clients
dietitians need to understand hormones. Woolsey concluded by saying that she believes “by not
being proficient in working with this syndrome, we are not as effective as we could be in the
fields of weight management, endocrinology, mental health, cardiology, bariatric and disordered
eating.”
There are no published guidelines on the nutritional management of PCOS by a
recognized and reputable organization that currently exist. The closest thing is the American
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Dietetic Association’s (ADA) position paper on weight management for adults in 2009 58 but it
is not specific to PCOS. This paper does highlight the importance for registered dietitians to
remain skilled in aspects of weight management, individualized weight loss interventions, and
the long-term sustainability of weight loss as part of their professional responsibility. To date,
no published studies have examined the role of dietitians in the US in the management of PCOS
nor have studies assessed the barriers dietitians face to get more involved with PCOS.
RDs are the food and nutrition experts and should be on the front-line working alongside
physicians and other practitioners to manage this complex syndrome. There is an unmet need for
position statements and evidence-based guidelines for weight-loss and management in
overweight and obese individuals with PCOS, and dietary guidelines for normal weight PCOS
patients.
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Chapter III: Methodology
Study Design
This formative study was designed to assess and describe current trends and potential
implications in multidisciplinary treatment across multiple providers and in particular, investigate
the role, importance and challenges for involving dietitians in the treatment of PCOS. This was a
two-phase study that involved a preliminary survey to reach a broad category of providers to assess
the current trends in PCOS treatment and explore potential implications for future multidisciplinary
clinics though qualitative and quantitative data. The second phase of the study was designed to
obtain rich-qualitative data that was more narrowly focused on the utilization, importance and
challenges for involving dietitians in the treatment of PCOS. As Morse and Field described,
qualitative research is meant to discover meaning and insight and not to measure the distribution of
attitudes across an entire population, therefore randomization and representativeness is not a
concern. 59
Sample
Phase one was a cross-sectional, anonymous, Internet survey. Phase two was a descriptive
study that relied on a purposive, non-probability sample that was selected based upon theoretical
sampling. According to Battaglia, the objective of obtaining a purposive sample is to logically
assume the sample is representative of the population by applying expert knowledge of the
population to select a sample that represents a cross-section of the given population. 60 It is not the
intent of this study to generalize the findings to the entire population of health care providers, but
to gain feedback from the leaders in the field of PCOS on the impact and barriers regarding
nutritional interventions and multidisciplinary PCOS treatment. Theoretical sampling is used to
strategically select the best participants based on their ability to provide the most information-rich
data. 61 Morse and Field describe this as selecting a sample based on what has been learned from
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previous sources, 59 which supported utilizing the data captured from the survey to effectively
recruit for the focus groups. The sample size for neither phase was pre-determined and recruitment
persisted throughout the duration of the data collection.
PHASE I: Survey
Recruitment
West Virginia University’s Institutional Review Board (IRB) approved this study in April
of 2013 (Appendix A). Practitioners who work with PCOS were invited to complete an Internet
survey (Qualtrics, Provo, UT). An announcement was sent out asking for their participation in the
survey to four list serves, various LinkedIn Groups (see Appendix C), and to individuals who were
identified by their research or in the field or their involvement with existing PCOS treatment
centers. Providers were encouraged to share the link with other providers so the response rate was
unknown. The providers who chose to participate were instructed to click on the link in the email
or posting that directed them to the online survey. A reminder email was sent out two weeks after
the initial posting. The link opened up to the cover letter informing them of the implied consent
and contact information of the research in case of any questions. The letter included information
about the researchers, the study, and the approval status of the WVU IRB approval. The next page
marked the beginning of the survey questionnaire, which was designed to take fifteen to twenty
minutes to complete.
Survey Instrument
The survey was an internet-based survey through Qualtrics (Provo, UT), which consisted
of 30 multiple-choice, multiple-response, and open-ended questions targeting information on
their demographics, current treatment facility and approach, and perspectives about future
multidisciplinary clinics. The open-ended questions allowed for more free-flowing feedback
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about their thoughts. This survey was designed based on current literature reviews and existing
multidisciplinary clinic data and was formulated with the help of expert review. Professionals in
the field including a physician, fertility specialist, dietitians, and a group of students piloted the
survey for feedback. The final survey was released and left open for two months (May 15th –
July 15th, 2013). The survey can be viewed in Appendix E.
Analysis
Responses from the survey were downloaded from Qualtrics (Provo, UT) and cleaned from
entry into SAS software (SAS 9.3, SAS Institute, Cary, NC) where the frequencies and averages
were analyzed.
PHASE II: Focus Group
Recruitment
An addendum was submitted to the WVU IRB and approved this addition of a focus
group to this study in January of 2014 (Appendix B). Theoretical sampling 61 was used to select
participants based on their potential to supply rich information. An invitation (Appendix F) was
sent out to responders from the original survey who submitted their contact information and
resided in the United States (n=22) inviting them to participate in a focus group. If respondents left
their phone number, they were also called for a verbal invitation (n=13). Respondents were then
asked for referrals to other professionals and the invitation was then extended (n=4). There were
an additional 12 email invitations sent out to health care professionals that were very specialized in
PCOS and that were located via Internet search. As part of the grounded theory, theoretical
sensitivity has been described by Glasser and Strauss as a way to ‘describe the wisdom that
researchers bring to an inquiry. 61,62 Once participants were identified a date and time sign up sheet
was distributed. A total of nine providers engaged in the series of focus providing a participating
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rate of 24% of those contacted. Contact information and mailing addresses were collected for the
sole purpose of mailing out the compensation after their participation in the focus group.
Focus Group Data Collection
Similar providers were placed together to promote group cohesiveness 63,64 and
compatibility; 65,66 for example, physicians were paired with other physicians and dietitians were
kept together as much as possible.
During the focus group, participants were asked to respond to a series of open-ended
questions. In each of the focus groups, the following questions were asked:
Table 2: Outline of Focus Group Questions
Focus Group Question Outline
1. Describe any nutritional interventions that you provide to your patients?
2. How is the dietary intervention and patient care communicated between providers?
3. When is dietary intervention warranted for a patient with PCOS?
4. How accessible are nutritional interventions for the majority of PCOS patients?
5. What are some of the challenges for getting dietitians more involved with PCOS?
6. Do you feel like providers know and understand the value of nutritional interventions for PCOS patients?
7. In your career, have you seen any shift in the awareness or interest of PCOS?

The script (Appendix G) included seven main questions to provide the general foundation
for each focus group but still allowed for fluidity and room for additional comments. This template
was used to ensure consistency for data collection but slight adjustments in prompts were made
due the findings in the previous focus group to support to utilize constant comparison as part of the
grounded theory. 61,62 Holloway and Wheeler feel that this method increases the quantity of the
data collected and helps to develop categories and theories with more saturation. 67 Birks and Mills
describe constant comparison as an inductive process that allows for the analysis to be grounded in
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the data and reconnects the data as the research develops the theory. 68 The focus group format
allowed the participants to engage in free-flowing conversation and promote the sharing of ideas,
feelings, and experiences that went beyond the information that was captured by a simple
questionnaire. The study participants were aware that there were no right or wrong answers and
that confidentiality measures would be taken to remove their identifying information from any
transcriptions. During the study, participants engaged with others via teleconference. All focus
groups were audio-recorded so that they could be later transcribed.
Analysis
For each focus group there was three dedicated note takers and one facilitator who were
kept consistent throughout the series. Braun and Clarke’s method 69 for thematic analysis in
addition to the grounded theory 62 was used to analyze the focus group data. In support of
concurrent data collection and analysis, which is a fundamental component of the grounded theory,
data was coded, reviewed, and discussed between each subsequent focus group. The focus groups
were all audio-recorded and transcribed into word document that was typed by the researcher. The
transcript was compared with each of the note-takers note to examine for discrepancies. The final
transcription was analyzed question by question to identify themes and sub-themes. The
transcripts were examined to determine how extensive the participants discussed topics. The
transcriptions were reduced to exclude any unnecessary words to facilitate the identification of
themes efficiently. Thematic analysis was used to sort through the reduced data. By using
thematic analysis we are relying on the content analysis, which in a qualitative study focuses on
intentionality and implications of the context. 69 After the themes are identified and coded they are
sorted and paired accordingly. Themes are identified with re-occurring context noted and
theoretical saturation was research when new analysis only produced codes that fit into existing
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categories. Glasser defined theoretical saturation as part of the grounded theo
theory
ry as met once the
properties and dimensions of the categories are fully explained
explained. 61
Timeline
The development of the survey
urvey tool used in this study took place from February 2013 –
April 2013.. WVU’s IRB approved th
the study in April of 2013 with an addendum for the focus
group approved again in January 2014. Recruitment for the survey component of this study took
place from April to June of 2014. The survey remained open from May 15th to June 15th, 2013.
Data analysis for the survey took place between July and November 2013. Survey participants
who included their contact information in the survey were contacted and scheduled in January
2014 to recruit for the focus groups. Focus groups were held during the
he last week of January 2014.
Data analysis for the focus groups took place in February 2014.
Figure 1: Timeline of PCOS Thesis Project
PHASE 1:
Survey Tool
Development
February April 2013

WVU's IRB
Approval
April 2013

Survey
Recruitment
April - June
2013

Survey Open
May 15th July 15th,
2013

Survey Data
Analysis
August November
2013

PHASE 2:
Focus Group
Planning
November January

WVU's IRB
Addendum
Approval
January 2014

Focus Group
Recruitment
January 2014

Focus Groups
Conducted
January 2014

Focus Group
Data Analysis
February 2014
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Chapter IV: Results
i. Survey Results
Demographics of the Survey Respondents
There was a total sample size of 261 responders with 117 completed surveys. The
majority of responders were female (159 females (78%) and 44 males (22%)). All responders
provided care to individuals with PCOS as a physician (n =138, 66%), dietitian/nutritionist (n=46,
22%), or other specialty (n=51, 22%) (Table 1). Sixty-six percent (n=135) provided care to PCOS
patients in a hospital or clinic setting, but 45% (n=92) practiced out of a private office, (n=17) 8%
in a research facility, and (n=9) 4% in a different outlet. Input from urban setting providers (n=98)
made up 70% of the responses, followed by a suburban (n=33, 23%) and then rural locations (n=9,
6%). Survey responses came from across the world with 64% from the United States (n=117) and
36% from outside the USA (n=67) based on self-reported locations. A summary of demographic
information can be seen in Tables 3-5. View regional distribution of responders in Figures 2 and 3.
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Table 3: Demographic characteristics of provider specialty – multiple selections possible (n=210)
Specialty

# Selected

% Selected

Physician

138

66

Dietitian/Nutritionist

46

22

Fertility Specialist

11

5

Researcher

8

4

Midlevel Providers (NP, PA)

7

3

Educator/Counselor

6

3

Lab Tech

3

1

Psychologist

2

1

Exercise Physiologist

2

1

Physical Therapist

2

1

Nurse

1

0

Other

9

4

Table 4: Breakdown of physician responders’ area of expertise – multiple selections possible
(n=115)
Specialty

# Selected

% Selected

General Pediatrics

7

6

Adolescent Medicine

37

32

Endocrinology

40

35

Gynecology

35

30

Integrative or Naturopathic Medicine

2

2

Dermatology

1

1
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Table 5: Demographic characteristics of survey respondents
Demographics

# Selected

% Selected

Sex
Male

44

22

Female

159

78

Hospital or Clinic

135

66

Private Office

92

45

Research Facility

17

8

Other

9

4

Urban

98

70

Suburban

33

23

Rural

9

6

Other

1

1

United States

117

64

67
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Setting for Care

Population Setting

Location

Outside of the United States

37

Figure 2:: USA regional breakdown of survey respondents (N = 74)

USA Regions
# of responders

18
15
12
9
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0

New England: MA, NH, VM,
MA, RI, CT
Mid-Atlantic: NY, PA, NJ
East North Central: WI, MI, IL, IN, OH
West North Central: MO, ND, SD, NE, KS, MN, IO

South Atlantic: DE, MD, DC, VA, WV, NC, SC, GA, FL
East South Central: KY, TN, MS, AL
West South Central: OK, TX, AR, LA
Mountain: ID, MT, WY, NV, UT, CO, AZ, NM
Pacific: AK, WA, OR, CA, HI

Figure 3:: World regional breakdown of survey respondents (N = 41)
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Treatment Center Demographics
The majority of clinics (n=79, 56%) have been open for more than 10 years, with 19%
(n=27) opening 5-10 years ago, 16% (n=22) opening 2-5 years ago, and only 9% (n=12) opening
within the past 2 years. Fifty-nine percent (n=79) of the responders treated PCOS in a
multidisciplinary setting, defined as utilizing at least two health care providers from different
specialties, whereas (n=56) 41% did not work in a multidisciplinary setting. Of the 140 responses,
79% (n=111) stated their facility treated PCOS comprehensively as opposed to just one approach
such as fertility. For the 29 clinics (21%) that did not provide comprehensive care, 21 clinics listed
their specialty and the most common focus was gynecology/fertility (n=9, 43%) followed by
nutrition/weight loss (n=8, 38%). Other responses included cardiology (n=1, 5%), endocrinology
(n=1, 5%), and primary (n=2, 10%). For those responders who were part of a multidisciplinary
team the breakdown of specialties involved are listed below in Table 6.
Table 6: Breakdown of specialty providers involved in multidisciplinary PCOS clinics (N = 132)
Specialty

# Involved

% Involved

Dietitian/Nutritionist

94

71

Physician

89

67

Nurse

63

48

Fertility Specialist

46

35

Mid-Level Providers (NP, PA)

37

28

Social Worker

37

28

Psychologist

34

26

Researcher

30

23

Educator/Counselor

20

15

Physical Therapist

14

11

Other

14

11

Exercise Physiologist

11

8
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About the Patients
The majority of clinics, 51% (n=62), reported having less than 10 PCOS patients that are
seen by any member in the facility each week; 30% (n=37) reported seeing 10-20 PCOS patients,
11% (n=13) reported seeing 20-30, and 8% (n=10) reported seeing over 30 patients in an average
week. When assessing the number average number of new patients that are seen for PCOS
treatment on an annual basis in theses clinics, the majority of clinics (n=121, 58%) treated less than
50 each year; 24% (n=50) clinics saw 50-100 new patients, 10% (n=20) saw 100-150, 2% (n=5)
saw 150-200, and 5% (n=11) saw over 200 new patients annually. The average youngest age of
patients (n=124) treated was reported to be 16.27 years old (median = 15, mode = 12, standard
deviation = 5.526). The average oldest (n=120) was 36.73 years old (median = 40, mode = 40,
standard deviation = 11.593). The greatest percentage of their patients were reported to be obese or
overweight with a combined average of 69.78% of patients and the average reported breakdown is
in Table 7.
Table 7: BMI category of patients treated for PCOS by survey responders (N=144)
BMI Category

Minimum %

Maximum %

Average %

Standard
Deviation

Underweight: <18.5

0

15

2.17

3.78

Normal: 18.5 – 24.9

0

50

13.13

12.21

Overweight: 25 – 29.9

0

90

33.07

22.93

Obese: >30

0

100

36.71
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The diagnostic criteria used to diagnose PCOS by the survey responders was similar
between teenagers and adults – see Figure 4. The most common diagnostic criteria used with
teenage patients was the 2003 Rotterdam Criteria with 52% (n=62), followed by the 2006
Androgen Excess Society (AES) criteria with 30% (n=36), the 1990 National Institute of Health
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(NIH) criteria with 28% (n=33),
33), and other with 16% (n=19). Responses for “other” used for
teenagers included using a combination of NIH 1990, ROT 2003, and AES 2006 (n=4); ACOG
(n=1); or minor changes in the ultrasound method.
The most common diagnostic criteria used with adult ppatients
atients was also the 2003 Rotterdam
Criteria with 53% (n=55), followed by the 2006 AES criteria with 26% (n=27), the 1990 NIH
criteria with 19% (n=20), and other with 15% (n=15). Responses for “other” for adults using a
combination of NIH 1990, ROT 2003, and AES 2006 (n=1); ACOG (n=1); or a consensus between
ASRM and ESHRE.
Figure 4: Breakdown of PCOS diagnostic criteria used by the survey respondents

Percentage of Providers

Diagnostic Criteria Used for PCOS Patients
60
50
40
Teenagers (n=119)
30
Adults (n=103)

20
10
0
NIH 1990

ROT 2003

AES 2006

Other

Diagnostic Criteria

Existing Clinic Outcomes
Responders (n=88) were asked to list the top one or two items that their facility could
improve upon. The most common theme identified in the responses, at 34% (n=30),
(n=30 was to
incorporate more multidisciplinary involvement with mor
more integration
ntegration and/or communication. The
second most popular theme, with 30% (n=26) was to expand on nutrition and/or exercise programs
to support weight loss. Improving
mproving or eliminating access barriers that prevent treatment of patients
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(n=9, 10%) were alsoo common themes. The three most common access barriers were identified to
be patient wait-time (n=5, 56%), cost (n=2, 22%), and health insurance (n=2, 22%).
%).
Responders (n=87) were also asked to list the top one or two items that their facility does
well. The two most common responses, with (n=18) 21% of responders each, were the
treatment/management of symptoms and nutrition/lifestyle changes; 20% of responders (n=17)
stated patient education/counseling. With 17%, multidisciplinary collaboration with other
oth
providers was the fourth most common theme identified (n=15).
Responders rated their practice setting on the following criteria: retention rate, waiting
time, prognosis outcomes, weight loss success, fertility outcomes, and patient satisfaction.

Figure 5: Self-reported
reported ratings for the responders
responders’ PCOS facility on the following criteria:
Wait Time
PCOS Prognosis
Patient
Retention
Rate
retention rate, wait time, prognosis, weight loss, and patient satisfaction
1%

6%
15%
28%

9%
22%

16%

30%
40%

33%

35%

29%

36%

N=134

N=134

Weight Loss

N=130

Fertility Outcomes
2%

6%
7%

11%

14%

15%
36%
30%
36%

N=134

43%

N=102
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The majority of respondents ((n=98,
n=98, 70%) reported that their PCOS treatment facility does
not collect
llect patient satisfaction data, where only 43 (30%) do collect patient satisfaction data to any
extent (N=141). For the clinics that reported collecting patient satisfaction data, the satisfaction
level was generally positive.
Figure 6:: Patient satisfaction data as self
self-reported
reported from survey respondents (N=40)

Patient Satisfaction Rating
3%
13%

Poor

6%

7%

Fair
38%

33%

Good
Very Good
Excellent
Mixed

Future Implications
The most common potential bbarriers
arriers to future multidisciplinary clinics noted by
responders (n=76) were: money and resources ((n=23, 30%), insurance/reimbursement (n
( = 20,
26%), difference of opinions (n=12,
n=12, 16%), and time (n=9, 12%). When asked to discuss the
potential advantages of multidisciplinary PCOS clinics the most common responses (n=82) were:
•
•
•
•
•
•

Ability to provide more comprehensive and integrated care to address all aspects of PCOS
(n=26, 32%)
Better results/long-term
term care outcomes ((n=12, 18%)
All-in-one location (n=12,
n=12, 15%)
Greater
reater convenience/efficiency ((n=12, 15%)
Allows for better coordination/communication/collaboration between providers (n=12,
(
15%)
Increased access to more disciplines ((n=8, 10%)
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In order to determine the perceived benefits and importance of the involvement of
specialties in future multidisciplinary clinics, responders were asked to rate the following
providers.
Table 8: Ideal involvement of specialties in future multidisciplinary PCOS clinics (N=113)
Specialty

N

Highly
Involved

Involved

Neutral

Occasionally
Involved

Never
Involved

Endocrinologist

109

48

36

6

7

3

Gynecologist

110

45

43

5

5

2

Physician (Other)

95

20

42

21

13

4

Dietitian/Nutritionist

110

59

30

6

3

2

Psychologist

105

11

45

21

15

8

Mid-Level Providers
(NP, PA)

90

17

31

29

11

11

Nurse

96

19

32

30

15

4

Exercise Physiologist

95

18

40

18

9

15

Fertility Specialist

97

30

33

14

13

9

Social Worker

93

10

25

31

22

13

Physical Therapist

90

6

24

30

20

20

ii. Focus Group Results
The purpose of conducting a series of focus groups was to further explore the topic of the
utilization of registered dietitians for nutritional interventions for patients with PCOS and gain
insight on the accessibility along with barriers and practicality.
Participant Demographics
The focus group participants included health care providers that fit in to one of the three
following categories: registered dietitians, physicians, and other practitioners. The other
practitioners consisted of one licensed nutritionist/certified nutrition specialist from functional
medicine and a health and medical psychologist. All providers treated patients with PCOS on a
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regular basis and had between 7-25 years of experience. We conducted a series of focus groups
via teleconferencing for a total of nine participants. The focus groups consisted of providers
from similar backgrounds (i.e. physicians were only paired with physicians) to promote
cohesiveness 63,64 and compatibility 65,66 as much as possible. Of the nine total participants, two
were male and seven were females. We spoke with three physicians, which included two
pediatric endocrinologist and one internal medicine/adolescent medicine physician, four
registered dietitians, one health psychologist, and one licensed nutritionist/certified nutrition
specialist. These providers primarily work in large metropolitan spread across the United States.
The majority (n=6) of participants worked in multidisciplinary facilities where they shared a
location with other types of providers; where as the remaining three providers were solo
providers who were in their own practice facility. Nearly all the providers in the focus group
were very well-versed in PCOS and had been working directly with patients with PCOS for a
range of 6-25 years.
Describe Any Nutritional Interventions That You Provide To Your Patients.
Physicians
The majority of physicians that participated in this series of focus groups, reported
collecting a basic diet history, determining food frequencies (of sugary beverages, dairy, etc.),
and briefly touching on nutrition education in their initial visits with patients. These physicians
also reported referring the majority of their patients to a dietitian for individualized counseling
based on the interventions the patient is receiving. The majority of physicians reported that they
are outliers in the fact that they focus heavily on nutrition in primary care and really value the
importance where that is not typical amongst physicians.
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Dietitians
All of the dietitians and other nutrition professionals that participated in the focus group
series reported conducting intake assessments, providing the bulk of the nutrition education, and
recommending a variety of individualized treatments depending on the patients’ co-morbidities
and goals. The dietitians are focusing on lifestyle interventions to manage their health, assessing
food coping mechanism, and exploring emotional or disordered eating habits. The dietitian will
also work with the patients to make sure that all patients are also seeing a physician who
specializes in PCOS so that they will be medically managed correctly. One provider stated
“Most of these women feel like they are not being listened to by the medical community –
specifically a lot their doctors just tell them to ‘eat less, exercise more’ but (are) not explaining to
them…how their insulin levels are really effecting everything else that is going on with their
bodies.” This was a common theme that was addressed frequently that a large part of these
nutritional interventions include helping the patient fully understand their condition and the
interventions they are undergoing to make the patient feel like they are in control of their health,
which makes them more likely to make changes.
When looking at the specific options the dietitians offer there were a variety of common
approaches that were discussed. One clinic works to reach every PCOS patient with nutritional
interventions by reducing the financial burden by offering group consultations and free monthly
support groups to increase accountability in addition to the standard individual consultations.
The frequency of visits with dietitians varied greatly depending on the patients and their
condition, their insurance or financial situation. For example if a patient is dealing with
emotional eating they will try to see that patient more often and one dietitian reported seeing the
best results when she sees patients at least once or twice a month. In one clinic that is

46

multidisciplinary and fully dedicated to PCOS, the patients always have the option to see a
dietitian and if there was a dietary change that was recommended at the previous visit then the
RD will be involved in the follow-up appointment.
As far as the specific interventions offered the most commonly discussed themes were
centered around managing insulin resistance and the majority of these dietitian suggested low
glycemic index diets, focusing on carbohydrate consistency, and reducing the size of
carbohydrate portions. Another common theme was the focus on general healthy eating
guidelines to reduce the risk of heart disease as well as improve their overall health. Another
theme mentioned was the correction of any nutrient deficiencies that may be common with the
medications typically prescribed for PCOS. Multiple dietitians mentioned the potential benefits
of sensible dietary supplementation, which included things like vitamin D, myo-inositol, and
others that have research supporting positive benefits with little or no side-effects. A few
dietitians mentioned the importance for RDs of recognizing the value of dietary supplements and
feel that physicians may value a provider that understands supplements and has that expertise.
One nutrition profession stated “It can be very easy to overwhelm patients so it is beneficial to
have a focused agenda and not try to cover everything in one visit.” Dietitians also frequently
mentioned the high need for individualized treatment because each patient will have different
goals and concerns and nutrition professionals need to gear the focus to match theirs because
even though providers can see the big connection and integration as a whole they might not see it
that way. The role of the RD for patients with PCOS is really to educate the patients about small
changes without overwhelming them and let the patients know that as a health care provider, you
are not there to lecture them but to help them understand their condition and education them with
compassion to better their health.
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Health Psychologist
These providers reported often seeing patients who are very frustrated because they have
read or heard so many different things about trying a variety of elimination diets and
supplements that they end up frustrated or overwhelmed and that is really where health
psychologist identified her role to be. The health psychologist reported that she emphasizes
motivational interviewing, explores emotional or mindless eating habits, and really works with
patient to facilitate that change according to the recommendations and education given by the
dietitian. She always pairs the patients with a dietitian and helps them find what works for them
so that they feel “like they are being proactive.” Health coaches were reported being involved in
one of the clinics and their role is to similar in the sense that they are there to assist patients with
making the changes suggested by the nutrition professionals and to facilitate the behavior
changes.
How are Dietary Interventions and Patient Care Communicated Between Providers?/ What
are the Potential Pros and Cons of Communication?
When looking at the communication that occurred through the providers in the focus
groups it did vary based on their practice setting. Overall, the providers who were located in
multidisciplinary care centers, where the dietitian and physician were in the same facility, there
was more verbal communication and integration of care. For some participants, being in the
same location allowed the physician to speak with the dietitians before and after they saw a
patient and meet in a shared conference space with all providers at the time of the patient visit.
Other clinics that included a dietitian and physician had less communication because of the
dynamic that the dietitian was brought in as an independent provider that solicited her services to
reproductive endocrinologists who are very busy with the fertility aspect that there is no
communication outside of the progress notes. There was very little formal case management
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meetings that was reported in the focus groups except for one clinic who held weekly case
management meetings with all providers for their PCOS patients who also had eating disorders.
Almost all of the participants stressed their desire for more communication between providers
but it just does not work the way their clinic is set up now but they do feel it. One provider
stated “In an ideal world, there would be PCOS treatment clinics all around the world and all the
providers would have the opportunity to converse about each patient.”
For those practitioners who are more solo providers there was no face to face
communication and the only communication was via email and progress notes and they did face
patient confidentiality barriers for discussing that patients care via email with other providers.
For these providers where they are not all located in the same facility the treatment is “really
piece milled out, which limits the opportunity for communication.” One dietitian stated that
once the doctors refer a patient to see her and she is actively treating that patient then the
physician stops paying attention to diet because they know the dietitian is focusing on that but
more integration and reinforcement can always help. The dietitians not located in
multidisciplinary facilities stated that although it is not ideal, “the way we handle communication
is still effective.” “Communication is important in any case but I think it really helps support the
patients so they know that we are all on the same page and the doctors can reinforce behaviors
such as eliminating soda and checking in to see if the patient is compliant and to discuss how that
it going and to provide extra support to the patient.”
When Do You Think Dietary Intervention is Warranted for a Patient With PCOS?/ How Does
this Differ For Patients Depending on BMI Status?
When is Dietary Intervention Warranted?
All providers involved in the focus group agreed and stated that it is always important to
discuss nutrition and provide nutrition counseling and that they are equally important for all
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patients with PCOS regardless of weight or BMI status. The majority of providers felt that
immediately upon on diagnosis of PCOS patients should meet with a dietitian for diet and
lifestyle intervention because across the literature that is considered to be the first line treatment
for PCOS. Providers stressed this importance and thought that diet needed to be addressed at
every visit with every patient. One provider stated that PCOS should be treated with the same
importance as any other chronic disease.
Why is Dietary Intervention Warranted?
As previously mentioned, diet and lifestyle intervention is considered the first line
treatment for PCOS therefore it should be warranted for every PCOS patient. One of the most
common themes addressed around the reasons PCOS patients need to see a dietitian was insulin
resistance, which does occur frequently in lean women with PCOS as well. Women with PCOS
who are overweight and obese are typically more symptomatic making them “more obvious
referrals” but it important to remember that PCOS carries an increase risk for developing
diabetes, heart disease, endometrial cancer even in lean PCOS. Another common theme across
all providers was that lean PCOS patients could still be very malnourished and have a poor diet
that will impact them later on in life.
What is Actually Happening?
Although all providers agreed that nutritional interventions are important for even women
with PCOS, not all women with PCOS are getting lifestyle interventions. The physicians all
agreed that not all patients with PCOS are typically seen by a dietitian and those who are lean are
often overlooked and not given the same access to referrals. One solo provider stated that she
rarely sees lean PCOS in her practice because they are just not referred there and the overweight
and obese PCOS patients are the ones who spend the most time with the dietitians. One provider
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summed up this topic by saying “Women with lean PCOS are highly overlooked by the medical
community because they don’t think nutrition can help them because they are already thin even
though a low glycemic index diet has been shown to increase ovulation and manage insulin
abnormalities. I have seen plenty of lean PCOS women and dietary intervention absolutely
helps!”
How Accessible are Nutritional Interventions for the Majority of PCOS Patients?
When the providers were asked how accessible they felt that nutritional interventions
were for the majority of PCOS patients, providers unanimously agreed that overall, they are not
very accessible. Factors that determine accessibility that were mentioned included their location,
the willingness of physicians to refer out, and their insurance coverage or financial situation.
Providers stressed that the biggest barriers are most likely insurance coverage and physicians that
do not refer out because they do not see the benefits of nutritional interventions. One provider
mentioned that without physician referrals, “It does not occur to most patients to seek out a
dietitian to visit on their own.” Of the participants in the focus group, one clinic only has access
to a dietitian for initial consultations and then any follow-ups must be done at a different facility
due to funding and as a result they see a lot of drop off for any follow-ups. Another facility
stated the only way they are able to have a dietitian present in their clinic is because they also
have a large diabetes program that covers the funding. It is important to address that these
providers feel that dietitians in general are more accessible but there are just not a lot of dietitians
who are well versed and experienced with PCOS. This is a very frustrating thing for providers
and patients to be able to located providers that understand PCOS.
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What are some of the Challenges for Getting Dietitians More Involved with the Treatment of
PCOS?
Insurance
The most common theme heard throughout the series of focus groups across multiple
questions was the insurance and reimbursement limitation for dietitians. Providers across the
board stated that most HMOs and insurance companies will not cover nutritional counseling or
will limit the number of visits to two-three per year, which does not allow adequate time to get
the maximum benefit. The amount of nutritional counseling that is typically covered varies from
state to state and does increase when PCOS patients also have conditions such as diabetes, which
are covered more commonly. It was mentioned that insurance companies often times do not see
a connection between nutrition and infertility. Unfortunately, when dietitians are not covered by
insurance this becomes a huge cost barrier to patients and an issue for dietitians because they are
not being reimbursed. One physician said “we are not able to effectively use dietitians because of
the lack of insurance coverage.”
Lack of Education
Another common theme addressed primarily by nutrition professionals and health
psychologist is that the majority of dietitians know very little about PCOS, let alone how to treat
it. The dietitians stated that PCOS is not covered in their education and dietitians have often
never heard of it. One provider said “There is no certification for PCOS so there is nothing
across the board that provides a certain protocol for treatment. There are a few diagnostic tools
but nobody has really agreed on which one to use.” The limited training for RDs on PCOS is a
huge problem and the profession needs to find a way to embrace this issue. It is very frustrating
for patients when they go see a clinician that is not familiar with PCOS and they just get told the
same information that does not help them.
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Lack of Physician Referrals
One of the most discussed themes was the lack of physician referrals for nutrition
interventions with PCOS patients. One potential reason for physicians not referring as often as
they should is the lack of insurance coverage. Most physicians stated that they feel more
providers would be happy to refer patients if it was covered by insurance. They also stated
physicians are likely not referring as often because of the limited access to dietitians who are
experienced with PCOS. Physicians need to be made aware that there are specialists out there
who can make a difference.
Another common theme across the series of focus groups was that physicians often times
are quick to write patients off as uninterested or noncompliant with lifestyle interventions. One
physician even stated that many physicians tend to not push lifestyle interventions because they
do not have a lot of confidence that it will make a difference in the majority of patients expect
the very highly motivated ones which he feels “are easy to pick out.” This provider stated
having similar thoughts and prior this focus group he has always viewed the dietitian as an
additional service their clinic providers instead of an integral role in treatment. Unfortunately,
the providers who have these beliefs are likely unaware of potential benefits when the nutritional
interventions are done as an integral component of treatment with experienced providers.
Another provider quoted “I just had a patient tell me that a doctor was just throwing people on
medication (insulin sensitizers) instead of also referring to a dietitian because he believes they
won’t follow through, so he doesn’t even try.”
Another common theme that provides rational why physicians may not refer patients for
nutritional counseling is that the physicians are so focused on intensely managing the
medications and treatments that they feel they have treatment covered. Providers stated that this
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concept is commonly seen with reproductive endocrinologist who are treating patients who are
often very eager to get pregnant that they are going to follow the more traditional pharmacology
route that dedicate that time to lifestyle intervention. Overall, physicians are thought to value
pharmacology over lifestyle interventions because of the higher compliancy rate which leads to
doctors feeling like that they treatment covered without any lifestyle interventions. One of the
physicians in the focus group stated that “some physicians just lack appreciation for what
dietitians do.”
The providers across these focus group feel like physicians have not been educated on the
importance of nutritional interventions and do not always see the value of referring out. A
dietitian summed up a major problem when she stated, “I think it is an education process that we
need to continue to educate dietitians, as well and physicians, that we can provide value for
PCOS treatment because physicians are the gatekeepers.”
Lack of Follow-Through from Patients
Another persistent theme throughout the series was that there is an additional set of
barriers that exist to explain why women with PCOS may not follow through with a dietitian
referral from a physician. The most common sub-theme was the lack of insurance coverage.
Additional barriers included the patients who are just not ready to make any changes. Regardless
of how much a patient may be in need nutritional intervention, if they are not ready to make a
change they will not follow through. Patients are often very overwhelmed and overload how
many providers they already need to see that they really do not want to take on another
component. It was also noted that the practicality of coordinating and scheduling another visit
that requires additional time off from school or work could deter patients from seeing a dietitian.
Providers stated that there is additional drop-off in following through with referrals when it
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requires a separate visits and then even greater drop-off when the dietitian is not located in the
same facility. Another common sub-theme was that many of these women are so damaged from
being lectured by health care providers about their weight without getting any help or
explanation of their condition. It was mentioned frequently that these patients are often not
treated with a lot of sensitivity so they are hesitant to see another provider for free of another
poor relationship. Participants mentioned that many people feel there is a certain stigma or it
may be viewed as punishment to be referred to a dietitian. Providers have heard they patients
say that they feel like they already know the dietitian is going to tell them and they already know
they “should eat carrots instead of a snickers bar” so why bother going because they do not
understand that it goes beyond that.
Various Challenges and Opinions
The providers in these focus groups had a variety of additional challenges that exist for
patients with PCOS and getting those patients the treatments they needed. Multiple providers
stressed the need for dietitian support for PCOS and that “PCOS is really calling for registered
dietitians and can potentially increase the need for what we do and really help a lot of people.”
Having a good dietitian who understands PCOS and how to effectively counsel patients with
PCOS can really be the gateway into proper medical care of that patient by gaining that patients
trust they will trust you when you advise them to see an additional provider. One provider
mentioned that PCOS is a difficult condition for internal medicine doctors because it is primarily
treated in the outpatient setting and the majority of programs that deal with internal medicine
physicians deal with inpatients so that could be one reason it is overlooked. When looking at
PCOS as a whole, another barrier that was mentioned was that “the diagnosis of PCOS in an
adolescent is very controversial and there are several groups out there that are looking in to
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different ways to define it in adolescents with various phenotypes and we may end up seeing that
these phenotypes require different dietary approaches.”
Importance of Involving Dietitians
One common theme discussing the importance of involving dietitians in the treatment of
PCOS patients was that it is the only way most patients will get adequate lifestyle interventions
and help understand their condition. It was mentioned that physicians should not be responsible
for the bulk of the nutrition interventions because they have little to no training in nutrition and
“they can only the experts on so many things.” These education sessions take time and it is so
much “more than just handing the patient a 1,200 kcal diet plan and some physicians do not
realize that.” Patients benefit from nutritional counseling so much more than handing out a diet
plan because there is a large psychological and emotional component related to food that much
be addressed. One provider stated “The dietitian providers the nutritional information and the
psychologist really gets the change.”
Do You Feel Like Providers Know and Understand the value of Nutritional Interventions for
PCOS Patients?/ What are Some of the Differences Between Different Types of Providers?
Physicians
The major theme identified in the responses of the series of focus groups was that overall,
health care providers do not understand the clinical complexities and the role of nutritional
interventions in PCOS very well. When looking at physicians overall, the majority of
participants felt that there were very few physicians that understand the value of nutritional
interventions for PCOS but the vast majority did not. The most common theme in regards to
physicians that was mentioned was that the majority of physicians do not understand the depth
that is required in nutritional interventions. A quote by the psychologist stated, “It is so much
more than handing them a diet plan and telling them to exercise and lose weight; It is about
56

trying to un-root deeply seeded behaviors that are tied to emotions.” Another common theme that
was mentioned was that physicians often feel like they have the condition handled with
medication and they tend to value pharmacotherapy higher than they do lifestyle interventions
because of perceived greater success and compliance. This being noted, it is predicted that
physicians do not see the value in referring out unless there is a major issue with diabetes, food
allergies, or possible severe obesity. A comment by a dietitian stated “Physicians often treat
PCOS with birth control pills and tell them to lose weight and exercise but do not do the followup monitoring or refer them to dietitians.” It was mentioned that physicians often do not
understand that the risk of developing long-term implications such as diabetes, heart disease,
high blood pressure, and infertility increase when PCOS is not treated in it’s entirety (by
including the lifestyle intervention). It was mentioned that a physician’s comfort level of
treating PCOS will differ by the type of patients you see and the way you treat PCOS will differ
across the specialties.
Registered Dietitians/Nutrition Professionals
The most common theme addressed when looking at the understanding of PCOS across
nutritional profession was that the vast majority of dietitians do not have a lot of training or
knowledge in PCOS. One provider summed it up by saying, “Nutrition professionals need to be
a lot better at what we do in terms of understanding PCOS and letting other providers know that
we need to be involved.” Two dietitians described personal experiences presenting information
at state and national conferences and being shocked at how many dietitians have never even
heard of PCOS when they can play such an integral role in the treatment of PCOS. One quote
stated, “PCOS is the most common endocrine disorder among reproductive age women and
dietitians don’t even know what it is. That is a big issue!”
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Implications and Suggestions for Change
Across the focus groups the common theme was the lack of understanding and with that
comes many implications. The most common implication was that the better the clinician
understands PCOS, the better they are able to treat it and the more value they will see in the role
of the dietitians and nutritional counseling. A major concern that was addressed was that when
providers that do not understand PCOS are providing care for PCOS and not getting positive
outcomes then it reflects poorly on the entire profession leading to poor relationships between
health care providers and the PCOS patients. When looking at ways to change the lack of
understand among providers it was mentioned that the first step is to just get the conversation
started at the primary care level and to help show physicians the added value to the patients
progress when dietitians and health psychologist are involved. One physician strongly believes
and expressed that every physician needs to be referring every PCOS patient to a dietitian. A
dietitian stated that she feels that “often times nutrition counseling is treated like dermatology
and it needs to be treated more like psychology.”
In Your Career Working With PCOS, Have You Seen Any Shift In Awareness or Interest of
PCOS?/ If So, Please Describe Any Changes You Have Observed?
The general consensus between providers across the focus groups was that they all felt
there is much more awareness and recognition in the medical community. Physicians noted that
they are speaking with their residents about it more often and the other providers mentioned that
there are now people who claim to have a specialty in PCOS, which did not used to be the case.
Another common theme identified was the they are noticing more information in the lay press so
more patients are actually being the ones to ask their doctors to be tested for PCOS. In terms of
the general public, these providers felt that there were more support groups and websites geared
to help these women. While awareness for PCOS seems to be increasing, it was heavily
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emphasized that many providers still do not understand it and the following comment sums up
the general consensus by saying “In general, women's health is not as much on the forefront and
because PCOS affects only women it's on the list; It’s starting to get mentioned but it doesn’t get
the attention it deserves."
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Chapter V: Discussion
The current formative study investigated the opinions of heath care providers who
frequently treat PCOS on potential implications for the role of dietitians in the multidisciplinary
treatment of PCOS. The hypothesis regarding the benefits of specialized individualized, and
multidisciplinary care was demonstrated. There were a variety of challenges preventing dietitians
from being involved to the fullest capacity with the treatment of PCOS.
Our survey found that 71% of individuals involved with a multidisciplinary clinic involved
a dietitian, but a study on UK dietitians who treated PCOS found that only 36% worked jointly
with other health professionals. 56 Because our study advertised assessing multidisciplinary PCOS,
it is likely that our sample attracted a higher percentage of multidisciplinary providers than is truly
representative. Our results were lower than the results of a study assessing clinical variability in
approaches to PCOS via a similar Internet survey to the NASPAG membership when they found
that 90% of physicians recommended diet modification/exercise for a first-line treatment done by
Bonny et al. 42 While our study included NASPAG list serve we also included other outlets for
recruitment which results in a different demographic between the two studies. Bonny et al. had a
sample of 64% gynecologist, and 34% adolescent medicine where our survey consisted primarily
of close to one-third of gynecologist, adolescent medicine, and endocrinologist. While this exact
question differed between surveys it could potentially show that members of the NASPAG who
completed the survey by Bonney et al. are in fact recommending lifestyle modifications but not
actually referring out to dietitians. Although this theory is just speculation, it is supported by the
other studies who saw very minimal interactions with the dietitians. 55,56 Jeanes et al. found that
only 17% of lean PCOS and 25% of overweight women with PCOS received dietary advice from
their physician. 56
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The limited accessibility to dietitians was addressed in our focus groups and it was
mentioned that when dietitians are in a separate facility and require a separate visit less patients
will actually see the dietitians. This study was a retrospective chart review in 2010 by Bekx et al.
that demonstrated that 43% of all new referrals saw the health psychologist, 66% saw the
nutritionist, 69% the gynecologist, and 100% saw the endocrinologist. These numbers are greatly
higher than the percentages of patients reported in other studies 55,56 and reflected in our focus
groups most likely because of the multidisciplinary clinic facility design. This same clinic was
assessed in another study by Geier et al. that looked at patient with a diagnosis of PCOS under the
Rotterdam criteria and they found that those numbers had increased to where 100% still saw the
endocrinologist, but now 60.9% saw the health psychologist, 75.5% saw the dietitian, and 70.9%
saw the gynecologist. 7 Again, these findings are much higher than the percentage of patients
seeing the dietitian that are not seen in these comprehensive multidisciplinary clinics and that were
expressed in our focus groups.
When looking at the benefits of dietitians in the treatment of PCOS there has only been one
study that assessed this so far. Geier et al. conducted a study at the American Family Children’s
Hospital in Madison, Wisconsin and assessed the factors contributing to the initial weight loss
among adolescents with PCOS. Geier et al. found that 71% of 110 patients returned for a followup visit at the clinic and of those 57% (45/78) succeeded at losing weight (mean loss of 3.5kg) and
a total of 70% demonstrated weight loss or weight stabilization between the initial and the followup visit with an interval of 4.5 month (1.5-12 month range). 7 When looking at the factors that may
have attributed to the weight loss they saw that when comparing the providers seen with the
relationship of weight loss, seeing a dietitian approached significance (p=0.06). It was not until
they looked at patients who had seen both, the dietitian and the health psychologist, that they saw a
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significant difference. The patients who did not see either provider reported a mean weight gain of
2.0kg ± 2.8 kg and the patient who saw both provider reported a loss of 1.3 kg ± 4.2 kg (p=0.02).
Seeing these providers had more of impact than being prescribed metformin, which had no
independent effect. 7
Results of our study supported the conclusions found by Bekx et al. that PCOS is a
complex and heterogeneous disorder that requires multidisciplinary treatment to manage patients in
the most effective way and the roles of each provider were similar to the themes of our focus
group. Bekx et al. stated that the health psychologist and the nutritionist included motivational
interviewing as a way to focus in on small lifestyle changes that were consistent and that were
most likely to lead to the most success. 39
The most frequent specific dietary intervention reported in our focus groups with the focus
on insulin resistance through glycemic index and altering carbohydrate consistency and portion
sizes. This was the same result found by Jeanes et al. in a survey focused on dietitians in the UK
who treated PCOS, who found that 78% recommended caloric restriction, and 77% recommended
choosing lower glycemic index foods, and often in combination. 56 Jeanes et al. found that the
dietary advice given to lean women with PCOS focused predominantly on reducing the glycemic
index, general healthy eating, and increased physical activity, which was similar to the results of
our focus group. Similar findings were reported in Bekx et al. that the nutritionist focuses on
improving insulin resistance with the avoidance of prolonged fast and fiber-rich carbohydrates and
protein. 39
The results of our focus groups signified that access to nutritional intervention counseling
is very limited for the majority of PCOS patients. Jeanes et al., who used a patient questionnaire to
survey women in the UK with PCOS to determine where they receive their nutritional information,
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supported this finding. This study found that only 15% of patients with PCOS had ever seen a
dietitian; that number was further reduced to just 3% for patients who had more than two
appointments with a dietitian. This study did not report how many of these patients had ever seen
a referral. Humphreys et al. 55 conducted in-depth interviews with PCOS patients in the UK and
found the only 26% of overweight or obese women with PCOS had ever received a referral to see a
dietitian, which also supported our findings of the limited access and the limited number of
physician referrals.
When assessing the differences in accessibility to dietitians and nutritional interventions in
overweight and obese verse women with lean PCOS the focus group results found that lean PCOS
is often overlooked and the obese PCOS cases are typically more symptomatic, making them more
obvious referrals despite the perception of it being of equal importance. This findings are
supported by Jeanes et al. who found that overweight women were more likely to receive dietary
advice from a dietitian (21%) than lean with 10% and from the physicians, with 25% and 17%
respectively. Humphreys et al. found that only the overweight women had been given dietary
advice from their consultant endocrinologist; the patients rated this information as useful but very
general and inadequate. 55
Geier et al. looked at barriers that existed to prevented all of the patients in a
multidisciplinary clinic setting to seeing the dietitian and health psychologist and found similar
results to the barriers identified in the both phases of the current study. The number one barrier
was the denial of access by referring HMOs or insurance providers followed by the patient refusing
the visit due to the perceived stigma or they did not want to consider dietary interventions.
Another barrier that was discovered by Geier that was not mentioned in our study was that some
patients had a prior therapeutic relationship was a psychologist or psychiatrist that was not
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affiliated with this multidisciplinary clinic. It was noted in this study that there was a lack of
perceived benefit from patients with PCOS that had a normal BMI, even though a few still had
insulin resistance. 7 This was similar to the concept addressed in the focus group that they already
know what the dietitian is going to tell them or that they think because they are already lean diet
changes won’t help them. The study by Geier et al. was a retrospective study that had no consistent
documentation for refusal reasons and it should be evaluated in a prospective study.
Our study noted that a major challenge to dietitians in the US in regards to treating PCOS,
was the lack of focused PCOS education for dietitians. Jeanes et al., who found that amongst UK
dietitians who treated PCOS only 34% reported feeling well informed of the PCOS literature, and
64% believed that there was insufficient evidence regarding the dietary management of PCOS in
2009, support this finding. 56 The fact that only one-third of dietitians who see women with PCOS
feel confident in their abilities to treat PCOS, supports the common focus group theme that there
are very few dietitians across the board that understand PCOS.
One major barrier for dietitians that our study found was the lack in physician referrals.
Potential reasons for the lack in referrals were noted to include the lack of confidence that
physicians have that lifestyle intervention is beneficial. These findings were supported by a study
by Foster et al. 70 that was a random survey of physicians that found that 43% of the physicians
surveyed think that most obese patients will not lose a significant amount of weight. The same
survey also demonstrated that only 14% of those physicians believe that they are usually successful
in assisting obese patients lose weight. Another study by Baillargeon et al. 71 demonstrated that
physicians are not comfortable discussing obesity and they believe it is not worth the time it takes.
A study by Pelletier et al. looked to determine the proportion of obese women with PCOS who
achieved clinically significant weight loss, defined as at least 5-10% of their initial weight when
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provided with only regular follow-up by an endocrinologist, without an integrated
multidisciplinary. This retrospective chart study did encourage participants to visit a dietitian but
this was not recorded and the dietitian located in the clinic was only accessible to the women who
had diabetes. The endocrinologist had 45-50 minute initial consultation and then follow-ups that
lasted about 25 minutes. During these visits the physicians explained PCOS, nutrition education –
regarding basic healthy items, and emphasized physical activity, which were all reinforced during
follow-up visits. This study found that over 40% of obese PCOS women lost ≥5% of their initial
weight after at least six months of follow-up with an endocrinologist and 20% lost ≥10% after one
year of follow-up. 72 This should provide physicians with more confidence that lifestyle
intervention is effective.
When assessing the importance of dietitians our focus groups conveyed that physicians
should not be the ones fully responsible for dietary interventions because they lack the training and
the time it takes to facilitate the change. Humphreys et al. noted that 80% of overweight PCOS
patients found weight loss difficult and only 23% have had success on their current weight
reduction diet. 55 These patients received their information from the Internet or their
endocrinologist whom they only saw twice a year, and remember that only 26% had ever been
referred to a dietitian. 55 A random survey of the American Medical Association in 2003 that was
conducted by Pelletier et al. determined that only 49% of physicians felt competent in prescribing
weight loss programs, which supports the theme identified in our focus groups that physicians do
not have the proper education for nutritional interventions. 72
Lifestyle intervention counseling is overlooked heavily in the treatment of PCOS and there
are many challenges to incorporating dietitians but with improvements in education and insurance
they can play an integral role in PCOS. Our study and the findings of others found that despite the
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fact that weight loss and weight maintenance are vital in the reducing of symptoms and long-term
risk for PCOS, the general consensus is that the education and support given to these patients is
inadequate.
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Chapter VI: Summary and Conclusions
PCOS is a complex condition that requires the expertise of multiple provider types to treat
the syndrome in its entirety. Most providers agree that a multidisciplinary clinic would provide
greater convenience, access to care, and ultimately lead to a better prognosis for patients with
PCOS. The perceived barriers that prevent clinics from becoming multidisciplinary would need to
be well defined, but providers indicate enthusiasm for the opportunity to implement a
multidisciplinary approach.
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Appendix A: IRB Approval & Addendum
WVU Institutional Review Board Approved Protocol H-24546 Title: Multidisciplinary Approach
to Treatment of PCOS including Nutrition Therapy on April 4, 2013 and Addendum Approved
on January 18, 2014
The 42 page document including consent can be found in the BRAAN 2 system with the tracking
number 24546.
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Appendix B: Survey Recruitment Distribution Sites
ListServs included:
•

Society for Adolescent Health and Medicine (SAHM)

•

North American Society for Pediatric and Adolescent Gynecology (NASPAG)

•

Society of Assisted Reproductive Technology – American Society of Reproductive
Medicine (SART-ASRM)

•

EmbryoMail

LinkedIn Groups included:
•

‘Academy of Nutrition and Dietetics’

•

‘Endocrinology’

•

‘Endocrinology Discussion Network’

•

‘Global Physician Assistant Professionals’

•

‘Nutrition Entrepreneurs Dietetic Practice Group’

•

‘Nutrition Health Providers and Professionals’

•

‘Obstetrics & Gynaecology Networking Group – Women’s Health’

•

‘Ovarian Club’

•

‘Pediatric Endocrinology’

•

‘Polycystic Ovary Syndrome Association of Australia’

•

‘Registered Dietitian Net’

•

‘SCAN: Sports, Cardiovascular, and Wellness Nutrition’

•

‘The Endocrine Society’

•

‘The Endocrine Society Interest Group’

•

‘Weight Management Dietetic Practice Group’

•

‘Women Nutritionist’
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Appendix C: Survey Announcement for List Serves and LinkedIn
DISTRIBUTED VIA LIST SERVES & LINKED IN
On behalf of a dietetic intern who compiled a survey to send to individuals/teams for care
for patients with PCOS:
Title: Special Request for Individuals Working Closely with PCOS
I am searching for individuals who work with PCOS patients who would be willing to
spend about 10 minutes filing out this survey to determine the current trends of PCOS
treatment from practitioners. It will also provide insight on future multidisciplinary
treatment for patients with PCOS. The West Virginia University Institutional Review
Board has approved this research study.
Link to survey: http://wvu.qualtrics.com/SE/?SID=SV_6Vxq8pJ3BZWrRqd
Your participation is greatly appreciated. If you have any questions please contact
Wendy Thompson directly at wmthompson@mix.wvu.edu
Wendy Thompson
Graduate Student - Nutrition
West Virginia University
Davis College of Agriculture, Natural Resources, and Design
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Appendix D: Survey Email Request
SENT TO: “PCOS SURVEY FROM LISTSERV”
Dear PCOS Practitioner,
Thank you for replying to my request seeking your expertise in PCOS treatment. Below is
the link to the survey that you previously expressed interest in taking. This survey should
take about 10 minutes to complete. If you are interested in receiving the results please leave
your contact information at the end.
Link to survey: http://wvu.qualtrics.com/SE/?SID=SV_6Vxq8pJ3BZWrRqd
The survey will be used to determine the current trends of PCOS treatment across
multiple providers around the globe. Your feedback will also provide insight on future
multidisciplinary treatment on patients with PCOS. This survey is being conducted by a
graduate student in Nutrition at West Virginia University, Wendy Thompson with
supervision by Dr. Melissa Olfert. Your participation in this project is greatly
appreciated. Should you have any questions, please feel free to contact Wendy Thompson
at wmthompson@mix.wvu.edu, or Dr. Melissa Olfert at melissa.olfert@mail.wvu.edu. The
West Virginia University Institutional Review Board has approved this research study.
Thank you for your time.
Sincerely,
Wendy Thompson
WVU Department of Human Nutrition and Foods
Melissa Olfert, DrPH, MS, RD, LD
Assistant Professor - WVU Human Nutrition and Foods
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Appendix E: Survey Email Reminder
Sent out: 5/28/13
SEND TO: “PCOS SURVEY FROM LISTSERV”
Dear PCOS Practitioner,
Thank you for replying to my request seeking your expertise in PCOS treatment. Below is
the link to the survey that you previously expressed interest in taking. If you have not gotten
a chance to take it, please take 10 minutes or less to complete the survey before it closes. If
you are interested in receiving the results please leave your contact information at the end.
Link to survey: http://wvu.qualtrics.com/SE/?SID=SV_6Vxq8pJ3BZWrRqd
The survey will be used to determine the current trends of PCOS treatment across
multiple providers around the globe. Your feedback will also provide insight on future
multidisciplinary treatment on patients with PCOS. This survey is being conducted by a
graduate student in Nutrition at West Virginia University, Wendy Thompson with
supervision by Dr. Melissa Olfert. Your participation in this project is greatly
appreciated. Should you have any questions, please feel free to contact Wendy Thompson
at wmthompson@mix.wvu.edu, or Dr. Melissa Olfert at melissa.olfert@mail.wvu.edu. The
West Virginia University Institutional Review Board has approved this research study.
Thank you for your time.
Sincerely,
Wendy Thompson
WVU Department of Human Nutrition and Foods
Melissa Olfert, DrPH, MS, RD, LD
Assistant Professor - WVU Human Nutrition and Foods
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Appendix F: Survey
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Appendix G: Focus Group Email Invitation
SENT TO: Survey Respondent’s with Contact Information in the US
Dear Participant,
Thank you again for your participation in the ‘current trends of PCOS
treatment across multiple providers’ survey. Your feedback has provided insight
on future multidisciplinary treatment on patients with PCOS.
In order to further explore and evaluate the potential future for multidisciplinary
PCOS clinics you are being asked to participate in a focus group. The focus group
will occur during the first two weeks of February. The duration will be 45 minutes
to one hour and will be conducted via telephone. The focus group will be facilitated
by a graduate student in Nutrition at West Virginia University, Wendy Thompson
with supervision by Dr. Melissa Olfert.
Your participation in this project is greatly appreciated and you will be
compensated with a $25 American Express gift card. If you are interested in
participating please respond to this email in the next two weeks and include your
profession (i.e. dietitian, physician, etc.).
Should you have any questions, please feel free to contact Wendy Thompson at
wmthompson@mix.wvu.edu, or Dr. Melissa Olfert at melissa.olfert@mail.wvu.edu.
The West Virginia University Institutional Review Board has approved this research
study.
Thanks,
Wendy Thompson
Graduate Dietetic Intern
West Virginia University
Davis College of Agriculture, Natural Resources, and Design
Division of Animal and Nutrition Sciences
Morgantown, WV 26505
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Appendix H: Focus Group Script
Opening (5 Minutes):
“Hello. My name is Wendy Thompson and I am a current graduate student in Human
Nutrition at West Virginia University. I also have two note takers, Jade White and
Makenzie Barr and my advisor, Dr. Olfert, here today. The objective of this focus group is
to further gather information on the nutrition interventions provided as part of
multidisciplinary treatment for patients with PCOS and identify the potential barriers for
why dietitians are not more involved. This FG is part of a larger study, which included a
survey to better understand multidisciplinary PCOS clinics. Our conversation today will be
about 45-60 minutes. Are there any questions?”
Respond to any questions.
“Let’s go over a some helpful tips. In order to best keep track of what people are saying
let’s try to only have one person speaking at a time. Just as a reminder this conversation
will be recorded but everything you tell us today will be kept completely confidential.
We will summarize the things you tell us and combine it with other focus groups we are
administering. Remember there are no right or wrong answers and we want to hear a
variety of viewpoints. One of my jobs today, as the moderator, is to make sure we
discuss all of the issues we planned to discuss and make sure everyone has a chance to
talk.”
“Just to get us started, let’s have you all tell us your first name and what type of facility
you treat patients with PCOS and a simple explanation of your role/title.”
“Let’s begin.”
Questions (40 minutes):
1. Describe any nutritional interventions that you provide to your patients.
a. Prompts:
i. Who provides the nutrition education/counseling?
ii. Do you refer patients to anyone?
iii. What is the extent of the intervention? (i.e. one session only, weekly
follow-ups, group settings, doctor recommends weight loss?)
2. How are the dietary intervention decided upon and communicated between providers?
a. Prompts:
i. Is there a protocol or pre-decided approaches?
ii. Does it only focus on weight reduction or does it include other
parameters?
iii. For example - macro or micronutrients/special diets?
iv. Is there any “case management” where all team members meet and
discuss the patients, their progress, and the care plan, etc. or does
everyone do their own thing?
v. Does case management seem to have potentially better outcomes?
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3. When do you think dietary intervention is warranted for a patient with PCOS?
a. Prompts:
i. Age?
ii. Weight category or status? (up to 40% of patients with PCOS can be
of “healthy weight”)
iii. What about dietary interventions for individuals of “normal” weight to
minimize symptoms and long-term disease risk?

4. In your experience, how accessible are nutritional interventions for the majority of
PCOS patients?
a. Prompts:
i. Do you feel that most patients with PCOS are provided with
nutritional education or a referral to an RD?
ii. Why are some patients not?
1. Does this differ based on weight status?
a. In your opinion, are PCOS patients of normal weight
given the same access to nutritional interventions?
iii. After the referral is given, do you think the majority of patients
actually see the RD?
5. In your opinion, what are the challenges for getting dietitians more involved with the
treatment of PCOS?
a. Prompts:
i. What are some potential reasons why physicians would not provide
nutritional education or a referral?
ii. What are potential barriers that would prevent patients from seeing a
dietitian – after referral is given?
1. What are potential reasons that they would choose not to?
iii. What are your opinions on the adequacy of evidence-based guidelines
for nutrition interventions?
iv. If guidelines were more prevalent – do you feel more dietitians would
get involved with PCOS patients?

6. Do you feel like other providers know or understand the value of nutritional inventions
for PCOS patients?
a. Prompts:
i. Does it differ by type of provider?
1. Other Physicians?
2. Other Dietitians?
ii. Who do you feel should provide PCOS patients with nutritional
counseling?
1. Are they any potential benefits to having an RD provide
nutrition counseling over a physician?
a. If so, what are some of those benefits?
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7. In your career with PCOS, do you feel there has been a shift in awareness or interest?
a. Prompts:
i. In the medical community?
ii. In the press?
Closure (2 minutes):
“Are there any final questions or comments? (Respond to questions as needed.) Thank
you for participating in the focus group today. We really appreciate all of your help and
are excited to learn about your thoughts regarding multidisciplinary PCOS treatment and
the benefits of nutritional interventions. We will be mailing you the gift card after the
call is over so please make sure we have your contact information.”
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